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Abstract A decade ago, the Society of Prevention Research
(SPR) endorsed a set of standards for evidence related to research on prevention interventions. These standards (Flay
et al., Prevention Science 6:151–175, 2005) were intended
in part to increase consistency in reviews of prevention research that often generated disparate lists of effective interventions due to the application of different standards for what was
considered to be necessary to demonstrate effectiveness. In
2013, SPR’s Board of Directors decided that the field has
progressed sufficiently to warrant a review and, if necessary,
publication of Bthe next generation^ of standards of evidence.
The Board convened a committee to review and update the
standards. This article reports on the results of this committee’s deliberations, summarizing changes made to the earlier
standards and explaining the rationale for each change. The
SPR Board of Directors endorses BThe Standards of Evidence
for Efficacy, Effectiveness, and Scale-up Research in
Prevention Science: Next Generation.^
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Introduction
A decade ago, the Society of Prevention Research
(SPR) endorsed a set of standards for evidence related
to research on prevention interventions. These standards
were intended in part to increase consistency in reviews
of prevention research that often generated disparate
lists of effective interventions due to the application of
different standards for what was considered to be necessary to demonstrate effectiveness. A committee of prevention scientists, chaired by Brian Flay, was convened
to determine the requisite criteria that must be met for
preventive interventions to be judged Btested and
efficacious^ or Btested and effective.^ The resulting
standards were articulated in a document published in
Prevention Science (Flay et al. 2005) and summarized
in more succinct form on the Society’s web page (http://
www.preventionresearch.org/StandardsofEvidencebook.
pdf). This work is frequently cited not only to justify
methods used in studies but also in debates about what
standards should be applied in prevention research. It
has been influential in the policy world as well.
In 2013, SPR’s Board of Directors decided that the
field has progressed sufficiently to warrant a review
and, if necessary, publication of Bthe next generation^
of standards of evidence. It noted that important research has been conducted in the past decade that might
alter design recommendations for efficacy studies, that
the earlier standards did not provide sufficient guidance
on standards for replication, and that the field had made
important strides in understanding prerequisites for scaling up of effective interventions that should now be
incorporated into the SPR standards. Hence, the Board
convened a second committee, chaired by Denise
Gottfredson, to review and update the standards. This
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article reports on the results of this committee’s deliberations, summarizing changes made to the earlier standards and explaining the rationale for each change.
In interpreting the SPR Board’s charge, the Committee
had to first clarify the intended purposes for the revised
document. Standards can be defined to map into current
practices to help maintain them or they can be purposefully set higher to encourage growth in the field. We
opted for the latter. For example, we identified numerous
ways in which early trials of an intervention can help to
provide information (e.g., about costs and variability in
the quality of implementation) that may not be critical in
the early stages of development but that will become
critical later. We also added a standard to encourage testing of the mediating pathways that are specified in the
theory of the intervention during the efficacy trial phase.
Clearly, it will take many years before researchers begin
to build these elements into their research proposals and
before funding agencies adapt their priorities to encourage inclusion of these elements in funded research. We
nevertheless believe it is important to articulate standards
that will provide direction to the field as it addresses key
scientific questions to better understand the effects of
preventive interventions and their potential public health
impact.
Given the forward-looking intent for the document, it is
important to clearly state that we would regard it as premature and inappropriate for many of the standards
contained in this document to be translated into requirements for interventions to be recognized as effective for
prevention practice today. Many organizations have developed standards to guide prevention practice (e.g.,
European Monitoring Centre for Drugs and Drug
Addiction 2011; U.S. Preventive Services Task Force,
http://www.uspreventiveservicestaskforce.org/) or have
applied reasoned standards to identify effective
interventions based on research currently available (e.g.,
University of Colorado’s Blueprints for Healthy Youth
Development (http://www.blueprintsprograms.com/);
Center for Disease Control and Prevention’s Guide to
Community Preventive Services (http://www.cdc.gov/epo/
communityguide.htm); Coalition for Evidence-Based
P o l i c y To p - T i e r E v i d e n c e I n i t i a t i v e ( h t t p : / /
toptierevidence.org/); U.S. Department of Education’s
What Works Clearinghouse (http://ies.ed.gov/ncee/wwc/);
Office of Justice Programs’ CrimeSolutions.gov; and
SAMHSA’s National Registry of Evidence-Based
Programs and Practices (NREPP; http://nrepp.samhsa.
gov/). The standards articulated in this document are
intended to elevate the rigor of the scientific evidence
that will be available in the future as these efforts are
renewed and revised. Likewise, although we anticipate
that the field will evolve as these standards begin to

guide publication and funding decisions in the future, it
would be inappropriate to use the standards articulated in
this document as a checklist of items that must be present
in a single work.
Definitions and Organization
The charge of the earlier committee was to Bdetermine the
most appropriate criteria for prevention programs and
policies to be judged efficacious, effective, or ready for
dissemination^ (Flay et al. 2005, p. 152, italics added).
We have opted to use the broader term, intervention,
throughout this document to include programs, policies,
and practices aimed at improving health and well-being
or at reducing disease and related problems. These interventions can target or affect units ranging from subperson
systems (e.g., the immune system) to defined populations
of individuals, to entire communities, states, or nations.
They include diverse activities ranging from changes in
individuals’ diets to influence brain chemistry, to sessions
for parents to improve family management practices, to
efforts to alter school climate and culture, to media messages, to community infrastructure changes such as improving the water supply, paving roads, or installing lights
in parking lots, to legislative action. An Bevidence-based
intervention^ (EBI) is an intervention that has been tested
in research meeting the efficacy standards described below
and that has been demonstrated in this research to achieve
statistically and practically meaningful improvements in
health and wellness or reductions in disease or related
problems.
An assumption on which these standards are based is that
high-quality research on such interventions will lead to beneficial change. We do not assume that such research is the only
mechanism for producing beneficial change or even the most
effective mechanism. The recent highly effective tobacco control movement, for example, involved communication of the
risks of smoking, advocacy, policy making, litigation, as well
as making smoking cessation supports widely available to
smokers. Sound research on the risks of smoking and the
effectiveness of specific strategies for reducing smoking were
necessary building blocks for this movement to occur, but not
sufficient to produce change without a range of additional
efforts aimed at translating the research into broad change.
As important as these nonresearch activities are producing
change, they are not the main focus of this document. Here
we articulate standards for high-quality research on specific
interventions that will hopefully provide the basis for sound
decision-making about which interventions should be
promoted.
The earlier standards were organized according to efficacy
research, effectiveness research, and broad dissemination
efforts. Flay et al. (2005) defined efficacy trials as studies of
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programs or policies delivered under optimal conditions, and
effectiveness trials as studies conducted in real-world conditions. They noted that these types of trials differ in the amount
of researcher control over potentially confounding factors,
with efficacy trials most often involving high researcher control over implementation and effectiveness trials involving
less. Flay et al. (2005) stated that effectiveness trials require
an additional burden of proof above and beyond that required
for efficacy trials because, for example, it is necessary to demonstrate that the intervention was in fact delivered under realworld conditions and that the outcomes are generalizable to
the population targeted by the intervention. Further, Flay et al.
(2005) argued that even interventions that have been demonstrated to be effective in the real world might not be ready for
broad dissemination. They therefore provided additional
criteria that must be met in order to justify a decision to broadly disseminate.
Flay et al. (2005) treated the Bbroad dissemination^ category differently than the efficacy and effectiveness categories.
They did not consider standards for research on broad
dissemination efforts, but rather assumed that once an
intervention had cleared all hurdles related to efficacy and
effectiveness, further rigorous research on its effects was not
necessary as long as fidelity to the proven model was
demonstrated. The earlier standards instead recommended
that monitoring and evaluation tools suitable for use by
practitioners be made available to adopting organizations so
that they could demonstrate to their constituencies that their
prevention dollars were well spent. The Flay et al. (2005)
document was therefore organized around the traditional preventive intervention research cycle (Mrazek and Haggerty
1994), which depicted a mostly linear progression (although
feedback across stages was anticipated) for prevention research beginning with basic research on the nature of the
problem to be addressed, progressing through the development of interventions, pilot testing, efficacy trials, effectiveness trial, and finally leading to broad dissemination. Each
phase focused on testing a different set of questions.
This framework was appropriate to describe the prevention
field 10 years ago, when Prevention Science was dominated
by studies of risk and protective factors and evaluations of
newly developed interventions. In the past 10 years, as it became clear that preventive interventions do indeed produce
desired outcomes at least under optimal conditions, the emphasis in Prevention Science has shifted more toward understanding how these EBIs can be implemented on a broader
scale to produce larger impacts on entire populations. A recent
report from an SPR task force on type 2 translational research
(Spoth et al. 2013) addresses the challenges to translating
EBIs into broader usage and sets an agenda for needed research to advance this new science of translation. This task
force recognizes that successful translation of EBIs into
broader usage will require a more elaborated and less linear

progression of research than is implied by the progression
from efficacy to effectiveness to dissemination in the prior
SPR standards. Specifically, it suggests that research on factors that are likely to influence the success of scale-up efforts
should be incorporated throughout each phase of the development and testing of EBIs. It also recommends a more collaborative, practice-oriented framework for developing EBIs than
is implied in the traditional preventive intervention research
cycle. Such a collaborative approach, implemented across all
stages of the development of EBIs, could yield rich information early on about the factors that are likely to influence the
success of attempts to move the EBI into broader usage later.
Spoth et al. (2013) also call for an increase in research on the
outcomes of scale-up efforts. This research is necessary because neither prevention interventions nor alternatives to these
interventions are static. Interventions may become more or
less effective relative to the usual state that would be present
in the absence of the EBI. Only by studying outcomes of
scale-up efforts will we learn how interventions work in these
new circumstances.
We incorporated this updated perspective into our revision
of the standards for evidence. We have used the term Bscaling
up^ to describe deliberate efforts to increase the impact of
EBIs. These include efforts to broaden the populations (broadly defined to include whatever unit is targeted) to which the
EBIs are delivered and the contexts in which they are implemented. As will become clear, we also added explicit standards to guide studies of the outcome of scale-up efforts. We
recognize that while some preventive intervention research
continues to be developed along a continuum, the progression
along this continuum often involves numerous critical feedback loops to inform needed research at earlier phases of the
research cycle. Often, effectiveness and scale-up research generate new questions that are later addressed in new efficacy or
effectiveness studies.
We also recognize that much valuable prevention research
does not follow the preventive intervention research cycle at
all. For example, evaluations of the effects of interventions
that are being widely implemented in a community but have
not previously undergone randomized efficacy trials have
great promise for identifying interventions with significant
public health impact. In addition, important work conducted
by economists, public policy analysts, and evaluation researchers often generates conclusive answers to questions
about what works under what conditions, while focusing less
on describing the intervention, testing the theoretical model
underlying the intervention, or creating conditions conducive
to subsequent scaling up. By organizing standards around the
preventive intervention research cycle, our intent is not to
question the value of efforts that are guided by these different
frameworks. We expect, rather, that the standards articulated
here may spur additional work to expand upon and complement these important works. For example, findings from
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evaluations of interventions that are delivered at scale may
generate additional questions to be tested by new efficacy
trials. Likewise, much can be learned about the factors
influencing adoption, implementation, and sustainability of
practices by conducting research on interventions that have
not been developed according to the sequence implied in the
preventive intervention research cycle.
Although we believe that continuing to recognize three
stages of research is helpful, we recommend flexibility in following the sequence implied in the standards. Although the
standards anticipate that certain questions will be answered at
certain stages of the research cycle, a more flexible approach
would allow researchers to take advantage of opportunities to
answer important questions whenever they are available. For
example, if the first trial of an intervention is a study of the
intervention as it is practiced population-wide, later trials
should seek to address questions that are more commonly
raised in efficacy and effectiveness trials. The main focus
should be on answering the questions implied for each stage
in the research progression rather than rigidly adhering to the
sequence at the expense of missed opportunities to contribute
valued research.
The standards are loosely organized around the types of
validity particularly critical for intervention research, as originally discussed in Cook and Campbell (1979) and elaborated
on in Shadish et al. (2002):
&

&

&

&

Statistical conclusion validity refers to the appropriate use
of statistics to infer whether the intervention is related to
the outcomes. Standards for statistical procedures to minimize threats to this type of validity are discussed primarily in the efficacy section.
Internal validity pertains to inferences about whether the
observed covariation between the intervention and the
outcomes reflect a causal relationship. Standards for the
design of the research and for minimizing threats to internal validity (such as differential attrition) are discussed
primarily in the efficacy section.
Construct validity pertains to inferences about higher order constructs that sampling particulars are thought to represent. Standards for describing the intervention and outcomes and for utilizing valid measures of them are
discussed primarily in the efficacy section.
External validity pertains to inferences about whether
the observed cause-effect relationship holds over variation in persons, settings (including different places
as well as different times), treatment variables, and
measurement variables. Standards related to external
validity are addressed primarily in the effectiveness
and scale-up sections.

Consistent with the Flay et al. (2005) report, we provide sections on standards required for establishing that

an intervention is efficacious, effective, and ready for
scaling up. The standards are cumulative. That is, unless
otherwise noted, all standards discussed for efficacy trials
also pertain to trials in later stages of intervention development and testing. We also provide standards to guide
decisions about the testing of outcomes of scale-up efforts. Although we retain unchanged standards, we discuss only modified and new standards, referring readers
to the original Flay et al. (2005) work for a rationale for
the unchanged standards. Standards that are taken with
little or no modification from Flay et al. (2005) are indicated in bold in Tables 1, 2, and 3. Standards are considered to be modified if their placement in the efficacy,
effectiveness, or broad dissemination section of the document has changed in this revision. In each section, we
separate standards related to the intervention itself (e.g.,
description, theoretical basis, manuals, training, and technical assistance available) from the standards related to
the conduct of studies of the intervention and standards
related to reporting of research results. Tables 1, 2, and 3
summarize the new standards.
Standards of evidence are expected to change over time
as methods develop and as Prevention Science and practice
advance. For this reason, we also include standards that are
desirable (labeled as such) though not essential given the
current state of program development and evaluation. Just
as we have upgraded many of the desirable standards of
Flay et al. (2005) to required standards, we anticipate that
many of our desirable standards may become required in
the future as knowledge accumulates and methods
advance.

Standards for Efficacy
Specificity of the Efficacy Statement [Reporting
Standard]
1. Standard: A statement of efficacy should be of the form
that BIntervention X is efficacious for producing Y outcomes for Z population at time T in setting S.^
Our first criterion pertains to the form of the efficacy statement. Because outcome research results are specific to the
intervention actually tested, the samples (or populations), the
point in time and settings from which they were drawn, and
the outcomes measured, it is essential that conclusions from
the research be clear regarding the intervention, population(s),
time, and settings, and the outcomes for which efficacy is
claimed. Subsequent studies should generalize beyond what
is likely to be a fairly narrowly defined set of conditions in the
efficacy trial.
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Table 1

SPR standards for efficacy

Number

Standards

1.

A statement of efficacy should be of the form that BIntervention X is efficacious for producing Youtcomes for Z population
at time T in setting S.^

Intervention description
2.a.
2.b.

The intervention must be described at a level that would allow others to implement/replicate it.
A clear theory of causal mechanisms should be stated.

A clear statement of Bfor whom^ and Bunder what conditions^ the intervention is expected to be effective should be stated.
The core components of the intervention and the theory relating these components to the outcomes must be identified and
described.
2.e.
The anticipated timing of effects on theoretical mediators and ultimate outcomes must be described.
2.f.
It is necessary to characterize the research evidence supporting the potential that the intervention will affect outcomes that
have practical significance in terms of public health impact.
Measures and their properties
3.a.
The statement of efficacy can only be about the outcomes that are measured and reported [Reporting Standard].
3.b.
The quality and quantity of implementation must be measured and reported.
3.b.i
Precursors to actual implementation must be measured and reported.
3.b.ii
The integrity and level of implementation/delivery of the core components of the intervention must be measured and reported.
3.b.iii
The acceptance, compliance, adherence, and/or involvement of the target audience in the intervention activities must be
measured and reported.
3.b.iv
Level of exposure should be measured, where appropriate, in both the treatment and control conditions.
D
Document factors related to the quality and quantity of implementation.
3.c.
Clear cost information must be reported [Reporting Standard].
D
Report cost-effectiveness information.
D
Collect data on outcomes that have clear public health impact.
2.c.
2.d.

D
3.d.
3.e.
3.e.i
3.e.ii
D
3.e.iii

Theory testing
4.
Valid causal inference
5.a.
5.b.

5.b.i
5.b.ii
5.b.iii
5.b.iv
5.b.v
5.c.

Measure potential side effects or iatrogenic effects.
There must be at least one long-term follow-up at an appropriate interval beyond the end of the intervention or, for ongoing
interventions, beyond the implementation of the intervention.
Measures must be psychometrically sound.
Construct validity—Valid measures of the targeted behavior must be used, following standard definitions within the
appropriate related literature.
Reliability—Internal consistency (alpha), test–retest reliability, and/or reliability across raters must be reported.
Use of multiple measures and/or sources.
Where Bdemand characteristics^ are plausible, there must be at least one form of data (measure) that is collected by
people different from the people who are applying or delivering the intervention. This is desirable even for
standardized achievement tests.
The causal theory of the intervention should be tested.
The design must have at least one control condition that does not receive the tested intervention.
Assignment to conditions needs to minimize bias in the estimate of the relative effects of the intervention and control
condition, especially due to systematic selection, and allow for a legitimate statistical statement of confidence in
the results.
For generating statistically unbiased estimates of the effects of most kinds of preventive interventions, well-implemented
random assignment is best.
Publications should specify exactly how the randomization was done and provide evidence of group equivalence
[Reporting Standard].
Well-conducted regression discontinuity designs are second only to random assignment studies in their ability to generate
unbiased causal estimates.
For some kinds of large-scale interventions where randomization is not practical or possible, comparison time series
designs can provide unbiased estimates of intervention effects.
Nonrandomized matched control designs rarely produce credible results. They should be used only under the certain
conditions specified in text.
The extent and patterns of missing data must be addressed and reported.
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Table 1 (continued)
Number
Statistical analysis
6.a.
6.b.
6.c.
6.d.
6.e.
Efficacy claims
7.a.
7.b.
7.c.
Reporting
8.

Standards

Statistical analysis must be based on the design and should aim to produce a statistically unbiased estimate of the
relative effects of the intervention and a legitimate statistical statement of confidence in the results.
In testing main effects, the analysis must assess the treatment effect at the level at which randomization took place.
In testing main effects, the analysis must include all cases assigned to treatment and control conditions.
Pretest differences must be measured and statistically adjusted, if necessary.
When multiple outcomes are analyzed, the researcher must provide a clear rationale for the treatment of multiple outcomes.
Results must be reported for every targeted outcome that has been measured in the efficacy study, regardless of
whether they are positive, nonsignificant, or negative [Reporting Standard].
Efficacy can be claimed only for constructs with a consistent pattern of nonchance findings in the desired direction.
For an efficacy claim, there must be no serious negative (iatrogenic) effects on important outcomes.
Research reports should include the elements identified in the 2010 CONSORT guideline or a relevant extension of these
guidelines.

Note: Desirable standards are shown in italics and denoted as BD^ in the Number column. Bold indicates that the standard has been taken with little or no
modification from Flay et al. (2005)

Intervention Description
2.a. Standard: The intervention must be described at a level
that would allow others to implement/replicate it, including the content of the intervention, the characteristics and training of the providers, characteristics and
methods for engagement of participants, and the organizational system that delivered the intervention.
2.b. Standard: A clear theory of causal mechanisms (including identification of mediators as well as outcomes)
should be stated.
2.c. Standard: A clear statement of Bfor whom^ and Bunder
what conditions^ the intervention is expected to be effective should be stated.
2.d. Standard: The core components of the intervention (i.e.,
those hypothesized to be essential for achieving the advertised outcomes) and the theory relating these components to the outcomes must be identified and
described.
A clear and complete description of the intervention is
necessary to guide practice, provide a basis for sound
measurement of its implementation, and for replication.
1

We are aware of the challenges related to identifying core components
of an EBI and the fact that the rigorous research necessary to adequately
test differential effects of different components of an EBI is rare in
Prevention Science (Elliott and Mihalic 2004). We suggest that the identification of core components is provisional and based on the developers’
theory of the intervention, but at the same time encourage an increase in
empirical testing of these components. See Efficacy Standard 4.

The standards for describing the intervention have been
modified from Flay et al. (2005) to require that in addition
to describing the intervention, an account of the theoretical mechanism through which the intervention is expected
to influence the outcome is also provided. Chen (1990)
and MacKinnon (2008) discuss the two components of
this theoretical mechanism: The Baction theory^ corresponds to how the treatment will affect mediators, and
the Bconceptual theory^ focuses on how the mediators
are related to the outcome variables. To meet this standard, authors should provide an account of both the action
and conceptual theories. Making these theories explicit
should help the developer to identify the features of the
intervention that are most central to the action theory.
These features should be clearly identified as the Bcore^
components of the intervention.1 These core components
should be fully described.
The statement regarding the conditions under which the
intervention is expected to be efficacious should clarify the
populations, settings, times, and outcomes, or the Brange of
application^ for the intervention. In so doing, the underlying
assumptions about hypothesized similarities in the causal
structure as well as anticipated limitations to application
across populations, settings, times, and outcomes will be documented. This statement should also define the broad target
for future dissemination if the intervention is demonstrated to
be effective.
The level of detail included in these statements describing
the intervention must be sufficient so that others would be able
to replicate the intervention.
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Table 2

SPR standards for effectiveness

Number

Standards

1.

To claim effectiveness, studies must meet all of the conditions of efficacy trials plus the following standards.

Intervention description
2.
Generalizability
3.a.
3.b.

3.c.
Population subgroups
4.
D
Intervention tested
5.a.
5.b.
5.c.
5.d.
5.e.
5.f.
D
Outcomes measured
6.a.
6.b.
D
Effectiveness claims
7.

Manuals and, as appropriate, training and technical support must be readily available
The degree to which findings are generalizable should be evaluated.
The target population and setting as well as the method for sampling both populations and settings should be
explained in order to make it as clear as possible how closely the sample represents the specified populations
and settings that define the broad target for future dissemination [Reporting Standard].
The sample should contain a sufficient number of cases from each of the dimensions across which intervention effects
are to be generalized to assess intervention effects in each subgroup.
Statistical analysis of subgroup effects must be conducted for each important subgroup to which intervention effects are
generalized.
Statistical analyses testing group differences in the causal mechanisms should be provided if such differences have been
proposed in the theory of the intervention.
The intervention should be delivered under the same types of conditions as one would expect in the community
institutions where such interventions are most likely to be situated during scale-up.
It is essential to compare the fidelity and quality of implementation/delivery of the core components of the intervention
to that achieved in efficacy trials.
The recruitment, acceptance, compliance, adherence, and/or involvement of the target audience and subgroups
of interest in the core intervention activities should be measured and reported.
Local adaptations to core components should be measured and reported.
Factors related to the quality of implementation should be measured and reported.
Convincing evidence that effects are not biased by investigator allegiance should be provided.
In at least one effectiveness trial demonstrating desired outcomes, a researcher who is neither a current nor past
member of the program developer’s team should conduct data collection and analysis.
The effects of an intervention must be practically important. Evaluation reports should report evidence of
practical importance.
Cost-effectiveness information should be reported.
Report cost-benefit information.

Effectiveness can be claimed only for intervention conditions, populations, times, settings, and outcome constructs for
which the average effect across all effectiveness studies is positive and for which no reliable iatrogenic effect on an
important outcome has been observed.
Research to inform scale-up efforts
D
Investigate the context, systems, and other factors that influence intervention adoption, quality implementation, and
sustainability of the EBI.

Note: Desirable standards are shown in italics and denoted as BD^ in the Number column. Bold indicates that the standard has been taken with little or no
modification from Flay et al. (2005)

2.e. Standard: The anticipated timing of effects on theoretical mediators and ultimate outcomes must be described.
The intervention theory should also clarify when (relative to
the intervention) the expected outcomes should be observed.
The description of timing of outcomes should be based on an
understanding of the developmental epidemiology of the
targeted behavior. Is the intervention expected to influence the
ultimate outcomes immediately (as, for example, adding

lighting to a parking lot would be expected to influence theft
from the lot), or is a lag anticipated (as, for example, encouraging attachment to school in elementary school children might
be expected to reduce substance use during adolescence)?
2.f. Standard: It is necessary to characterize the research
evidence supporting the potential that the intervention
will affect outcomes that have practical significance in
terms of public health impact.
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Table 3

SPR standards for scaling up (broad dissemination)

Number

Standards

1.

Only EBIs that have met all effectiveness criteria should be made available for scaling up.

Readiness for scaling up EBIs
D
D
2.
Materials
3.
Training and technical assistance
4.a.
4.b.
Fidelity assessment
5.a.
5.b.
5.c.
D
Improving the reach of the EBI
6.
Studying outcomes of scale-up efforts
7.
D

Prior to scaling up, it is desirable to assess readiness and to use the assessment in planning.
It is desirable for the scale-up effort to be implemented in the context of an organization development
intervention to support the adoption, implementation, and sustained use of an EBI.
Clear cost information and cost tracking and analysis tools that facilitate reasonably accurate cost
projections and are practically feasible must be made available to potential implementers.
To be ready for scaling up, materials that specify the activities to be carried out and optimal methods
of delivery must be available.
To be ready for scaling up, training for implementing the core components of the intervention must be
available.
To be ready for scaling up, technical assistance must be available.
Fidelity monitoring tools must be available to providers.
A system for documenting adaptations to core components should be in place prior to initiating the EBI.
Adaptations should be addressed in ongoing technical assistance activities.
A system to support regular monitoring and feedback using the available implementation monitoring tools
should be in place.
Normative data on desired levels of implementation keyed to the available implementation measures should
be provided.
A system should be in place to support planning and monitoring of client recruitment.
Scale-up efforts should be rigorously evaluated to ensure that at least the anticipated immediate effects are
observed on outcomes of practical importance when the intervention is implemented on a population level.
Before initiating rigorous scale-up research, it is desirable to conduct an evaluability assessment.

Note: Desirable standards are shown in italics and denoted as BD^ in the Number column. Bold indicates that the standard has been taken with little or no
modification from Flay et al. (2005).

Demonstrated public health impact is essential at a later
stage of program development, but it should not be ignored at the efficacy stage. This standard requires that
an argument be made connecting the observed outcomes
to outcomes of practical significance. This connection can
be accomplished by collecting and reporting data on such
outcomes (e.g., number of subjects who stopped using
tobacco as a result of the intervention; number of child
abuse and neglect cases or crimes prevented, increases in
number of high school graduates). If such outcomes are
not available at the efficacy trial stage, a logical argument
can be made to connect the available outcomes with outcomes of practical significance. For example, a study may
collect data on known precursor of criminal activity such
as low self-control or poor parental supervision. Making
use of data collected by others that links these proximal
outcomes to outcomes of practical importance, the researcher can characterize the potential of the intervention
to produce practically meaningful outcomes.

Measures and Their Properties
3.a. Standard: The statement of efficacy can only be about
the outcomes (e.g., mediators as well as problem and
well-being outcomes) that are measured and reported
[Reporting Standard].
3.b. Standard: The quality and quantity of implementation
must be measured and reported.
3.b.i. Standard: Precursors to actual implementation
such as completion of training, practitioner-coach
ratio, caseload, staff qualifications, and availability of necessary resources must be measured and
reported.
3.b.ii. Standard: The integrity and level of implementation/
delivery of the core components of the intervention
must be measured and reported.
3.b.iii. Standard: The acceptance, compliance, adherence,
and/or involvement of the target audience in the intervention activities must be measured and reported.
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3.b.iv. Standard: Level of exposure should be measured,
where appropriate, in both the treatment and control
conditions.
Implementation fidelity influences intervention outcomes (Durlak and Dupre 2008; Fixsen et al. 2005),
and the quality of implementation of preventive interventions when delivered in Breal-world^ settings is often
suboptimal (Gottfredson and Gottfredson 2002; Hallfors
and Godette 2002; Ennett et al. 2003). Assessing implementation fidelity and quality is an important activity at
all stages of development of an EBI (Allen et al. 2012),
and tools to guide researchers in the reporting of implementation fidelity (e.g., Oxford Implementation Index,
Montgomery et al. 2013a) are available. It is important
to understand the extent to which the core components
of the intervention can be varied and still achieve the
desired effect and to document modifications that occur
in the field. Although information on the quality and
quantity of implementation will become more important
in later stages of research, it is essential that such information be collected and reported in earlier trials that
produce desired outcomes. This information will provide
a benchmark against which implementation levels in later trials can be compared.
The level of implementation of the intervention is
meaningful only in comparison to what is present in
the comparison condition. Many interventions contain
elements that are likely to be present in the comparison
group as well as in the treatment group. For example,
most drug treatment courts involve intensive probation,
frequent judicial hearings, drug testing, and drug treatment. A lower dosage of these same components is
likely to be part of usual service for a Btreatment as
usual^ comparison group. Similarly, interventions that
are related to the intervention of interest may be present
in the control condition. It is important to document the
differences between the services provided to the treatment and comparison groups while taking care not to
allow the measurement itself to influence what is delivered in the control condition.
Desirable Standard: It is desirable to document factors
related to the quality and quantity of implementation.
It is desirable during the efficacy trial period to assess
not only the quality and quantity of implementation
(Efficacy Standard 3.b.), but also the factors that are likely to be related to variation in implementation. These factors include features of the intervention such as amount
and type of training involved in implementing the intervention during the efficacy trial, the clarity of the intervention materials, the type of setting in which the

intervention is tested, and external (social, economic,
and political) forces in the larger community. Many efficacy trials are small in scope and would therefore not
provide sufficient variability across different conditions
of these factors to provide useful data without deliberate
manipulation. Spoth et al. (2013) recommend embedding
research on factors that are likely to be relevant in the
dissemination stage (e.g., factors that might influence implementation quality when delivered in natural settings,
factors that might influence communities’ decisions to
select or adopt the intervention, etc.) into earlier stage
research studies. Efficacy studies, for example, might randomly assign units to different levels of training and technical assistance, or to different levels of organization development assistance. Short of conducting this type of
rigorous research on these factors, qualitative data on factors that are perceived to be related to implementation
quality would provide a useful starting point for more
thorough investigation into these factors at a later stage.
3.c. Standard: Clear cost information must be reported
[Reporting Standard].
Flay et al. (2005, p. 167) included a standard stating that
Bclear cost information must be readily available^ before an
intervention is ready for scaling up. A discussion of the types
of costs that should be included in the cost calculation was
also provided. Glasgow and Steiner (2012) and Spoth et al.
(2013) underscore the need for such information in community decisions to adopt and to sustain evidence-based practices
later on. Prevention scientists can begin to pave the way for
accurate cost tracking during the efficacy trial stage by
documenting program costs.
Of course, assessing costs is not straightforward. There is
currently no accepted standard to guide cost assessment, and
considerable variability exists in what elements are included.
Costs incurred during efficacy and effectiveness trials are likely to include significant costs related to conducting the research that are difficult to separate from the costs likely to be
incurred by communities later adopting the intervention.
Further, costs are likely to change over time as programs
evolve. The Institute of Medicine recently held a workshop
on standards for benefit-cost assessment of preventive interventions (http://www.iom.edu/Activities/Children/
AnalysisofPreventiveInterventions/2013-NOV-18.aspx), and
a recently formed SPR task force is studying this topic and
will soon provide much needed guidance in this area.
Prevention scientists should be guided by the forthcoming
recommendations of these groups. In the meantime,
investigators are encouraged to include in their cost
reporting not only the cost of intervention materials and
training, but also projected costs to the delivering
organization, as discussed in Flay et al. (2005). These include:
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Nonresearch investments in delivery of staff training
On-site time
Facility, equipment, or resource rental and maintenance
Reproduction of materials
Value of volunteer labor and donated space and equipment
Attendant delivery costs for consultants, clerical staff, and
physical plants

Foster et al. (2007) provide a more detailed discussion of
cost elements in prevention interventions and how they can be
measured.
Desirable Standard: It is desirable to report costeffectiveness information.
Researchers do not usually estimate cost-effectiveness
in efficacy trials. Even at the efficacy level, however, it
is desirable to estimate cost-effectiveness (i.e., the cost of
achieving the observed change in the outcome). This
information will influence decisions to adopt the intervention at a later stage and so should be collected during
earlier stages if possible.
Desirable Standard: It is desirable to collect data on
outcomes that have clear public health impact. 2
Desirable Standard: It is desirable to measure potential
side effects or iatrogenic effects.
3.d. Standard: There must be at least one long-term followup at an appropriate interval beyond the end of the
intervention. For policy interventions whose influence
is expected to continue for an indefinite period of time,
evidence must be presented for a sustained effect of the
policy for an appropriate interval after the policy was
put in place.
The positive effects of an intervention may diminish rapidly or slowly, or broaden and increase over time. Some interventions may demonstrate effects on problems that emerge
later in development, such as substance use or abuse, sexual
behavior, mental disorder, criminal behavior, or drunk driving
(Griffin et al. 2004; Olds et al. 2004; Wolchik et al. 2002).
Flay et al. (2005) recommended a follow-up interval of at least
6 months after the intervention but noted that the most appropriate interval may be different for different kinds of interventions. We believe that the 6-month time frame is a reasonable
minimum time frame to demonstrate that effects observed at
the end of the intervention do not dissipate immediately, but a

See effectiveness standard 6.a for discussion of meaning of Bpublic
health impact.^

2

more accurate picture of intervention effects requires that measurement time points coincide with the theory of timing of
intervention effects specified in the intervention description
(see above). This theory should be developed based on an
understanding of the developmental epidemiology of the
targeted behavior. For example, to demonstrate efficacy of a
fifth grade intervention on outcomes that arise during adolescence, it is necessary to include measurement during adolescence rather than after 6 months. The causal theory linking the
intervention to the ultimate outcomes (see Efficacy Standard
2.e.) should specify proximal outcomes and the expected
timing of effects on them. The timing of measurement of both
the proximal and ultimate outcomes should conform to this
theory.
3.e. Standard: Measures must be psychometrically sound.
The measures used must either be of established quality, or
the study must demonstrate their quality. Quality of measurement consists of construct validity and reliability.
3.e.i. Standard: Construct validity—Valid measures of the
targeted behavior must be used, following standard
definitions within the appropriate related literature.
3.e.ii. Standard: Reliability—Internal consistency (alpha),
test–retest reliability, and/or reliability across raters
must be reported.
Desirable Standard: It is desirable to use multiple measures and/or sources.
3.e.iii. Standard: Where Bdemand characteristics^ are plausible, there must be at least one form of data
(measure) that is collected by people different from
the people who are applying or delivering the intervention. This is desirable even for standardized
achievement tests.

Theory Testing
4. Standard: The causal theory of the intervention should be
tested.
Although the primary emphasis in efficacy trials is on demonstrating that an intervention is efficacious for producing
certain outcomes, understanding the causal mechanism that
produces this effect will allow for greater generalization to
the theory of the intervention rather than to the specific components of the intervention. For example, the knowledge that
implementing a specific model of cooperative learning in a
classroom increases achievement test scores is valuable. But
knowledge that the mechanism through which this effect
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occurs is increased time on-task is even more valuable because it facilitates the development of additional interventions
that can also target the same mediator. It is therefore important
to measure the theoretical mediators that are targeted by the
intervention.
As noted earlier (see Efficacy Standard 2.d.), the intervention theory involves both an Baction theory^ of how the treatment will affect mediators and a Bconceptual theory^ of how
the mediators are related to the outcome variables. Both aspects of the intervention theory should be tested at the efficacy
stage. Tests of the action theory probe the extent to which each
core component influences the mediators it is hypothesized to
move. The strongest of such tests would systematically
Bdismantle^ the intervention into core components. That is,
they would randomly assign subjects to conditions involving
different core components and compare the effects of the different combinations on the hypothesized mediators. Of
course, such designs are seldom feasible when the subjects
are schools or communities. However, testing for intervention
effects on the hypothesized mediators would provide a test of
the action theory of the intervention as a whole.
Testing the conceptual theory involves analysis of mediating mechanisms. Despite recent advances in methods for
testing mediational processes (e.g., MacKinnon 2008), these methods are not as well developed as are methods for
testing casual effects of the intervention. Intervention theories often involve complex causal processes involving numerous mediators operating in a chain. Testing such complex causal chains in a rigorous fashion is not yet possible
with existing tools (Imai et al. 2012). Even for simple theories involving only one mediator, it is not possible to test
the theory underlying the intervention except in comparison
with another theory. Available tools allow only for a rudimentary examination of the behavior of theorized mediating variables. Even so, such rudimentary tests can provide
valuable information about which of the proposed mediators are both responsive to the intervention and correlated
with the outcomes. Such information, although not constituting a strong test of the full intervention theory, at least
provides information about which mechanisms are consistent with the stated theory. These tests should be conducted
at the efficacy stage.
We caution that high-quality measurement of theoretical
mechanisms will often be costly because it may require additional measurement waves between the intervention and the
ultimate outcome as well as additional modes of measurement
(e.g., observations). In some cases, the ultimate outcome may
be decades in the future. Although measuring and testing
causal mechanisms is critical to advancing science, in reality
doing so may require trade-offs with the strength of the test of
the effect of the intervention on the ultimate outcome. This
trade-off creates tension that will have to be resolved over time
as mediation analysis strategies improve and funding sources

increase funding to allow for more rigorous testing of theoretical pathways through which interventions affect outcomes. In
the meantime, this tension should be resolved in a way that
preserves the integrity of the test of the intervention on the
outcomes.
Valid Causal Inference
5.a. Standard: The design must have at least one control
condition that does not receive the tested intervention.
The control condition can be no-treatment, attention-placebo, or wait-listed. Or, it can be some alternative intervention or
treatment as usual (e.g., what the participants would have
received had the new interventions not been introduced), in
which case the research question would be, BIs the intervention better than a current one?^
5.b. Standard: Assignment to conditions must minimize bias
in the estimate of the relative effects of the intervention
and control condition, especially due to systematic selection (e.g., self-selection or unexplained selection),
and allow for a legitimate statistical statement of confidence in the results.
Although there are many sources of bias in the estimation
of causal effects, selection effects are the most serious and
prevalent in prevention research. Researchers should assign
units to conditions in such a way as to minimize these biases.
Such assignment reduces the plausibility of alternative explanations for the causes of observed outcomes. This then increases the plausibility of causal inference about the intervention. The design and the assumptions embedded in the design
must take into account exactly how people or groups were
selected into intervention and control conditions and how influences on the treatment and control conditions other than the
intervention might differ.
5.b.i. Standard: For generating statistically unbiased estimates of the effects of most kinds of preventive interventions, well-implemented random assignment is best
because it is most clearly warranted in statistical
theory.
Within the context of ethical research, it is necessary to use
randomization whenever possible to ensure the strongest causal statements and produce the strongest possible benefits to
society (Fisher et al. 2002). Many objections to randomization
may be unfounded (Cook and Payne 2002). Randomization is
possible in most contexts and situations. Gerber et al. (2013)
provide numerous examples of RCTs conducted to test policies in diverse areas such as migration, education, health care,
and disease prevention. The White House recently sponsored
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an event to encourage the use of RCTs to different policy
options for social spending (http://www.whitehouse.gov/
blog/2014/07/30/how-low-cost-randomized-controlled-trialscan-drive-effective-social-spending). In fact, the Cochrane
registry (www.cochrane.org) contains over 700,000 entries
on randomized trials. The level of randomization should be
driven by the nature of the intervention and the research
question. Randomization can be of individuals or of intact
groups such as classrooms, schools, worksites,
neighborhoods, or clinics (Boruch 2005; Gerber et al. 2013).
Also, the timing of intervention can be randomly assigned to
allow a short-term comparison of outcomes between the early
and later intervention groups.
5.b.ii. Standard: Reports should specify exactly how the randomization was done and provide evidence of group
equivalence. It is not sufficient to simply state that
participants/units were randomly assigned to conditions [Reporting Standard].
Because correct randomization procedures are not always
implemented or sometimes break down in practice, it is essential that the randomization process be described in sufficient
detail so that readers can judge the likelihood that the initial
randomization process was correct and has not broken down
despite being initially implemented correctly. The description
of the process should include details of exactly how cases were
assigned to conditions and a discussion of the extent to which
the assignment was well concealed, or could have been guessed
at or tampered with. A Bwell-implemented^ random assignment is one in which this possibility is judged to be small.
Post-randomization checks on important outcomes measured
prior to the intervention should be provided so that the pretreatment similarity of the experimental groups can be assessed.
Although random assignment is the strongest possible design for generating statistically unbiased estimates of intervention effects, and although perceived obstacles to random assignment are often not as difficult to overcome as initially
anticipated, random assignment studies sometimes involve
important trade-offs, especially in terms of generalization or
statistical power. Researchers must sometimes rely upon fallback designs, hoping that the estimates of effects produced
using these designs approach those that would be obtained
through a random assignment study. There has been much
debate about which designs should be considered as suitable
alternatives when the trade-offs involved in random assignment are too costly. Fortunately, evidence from within-study
comparisons of different alternatives versus random assignment have yielded invaluable information about which designs are likely to yield results most comparable to those obtained from random assignment studies. These within-study
comparisons directly compare the effect size obtained from a
well-implemented random assignment design with the effect

size from a study that shares the same treatment group as the
randomized study but has a nonrandomized comparison group
instead of a randomly formed one. In these studies, the effects
size obtained from the randomized arm of the study serves as a
benchmark against which to compare the effect size obtained
from the nonrandomized arm of the study.
Cook et al. (2008) summarize what has been learned from
within-study comparisons and report results from 12 recent
studies in an attempt to identify features of nonrandomized
designs whose results match those from randomized designs
most closely. This research identifies only two alternative designs, regression discontinuity designs and comparison time
series designs, which reliably generate unbiased estimates of
treatment effects. There are now a total of seven studies comparing regression discontinuity and experimental estimates at
the regression discontinuity cutoff score and there are six comparing experimental and interrupted time series or comparison
time series designs with a nontreatment comparison series. All
point toward the causal viability of the quasi-experimental
design in question. The third design considered in Cook
et al. (2008) involves matched comparison group designs
without a time series structure. In their paper, the results from
these designs approach those of random assignment studies
only under certain restrictive conditions—when the selection
process happens to be completely known and measured well
and when local intact comparison groups are chosen that
heavily overlap with treatment groups on pretest measures of
the outcome. Since then, somewhat conflicting claims have
been made about the other quasi-experimental design features
that promote causal estimates close to those of an experiment.
The regression discontinuity, comparison time series, and
matched group designs are described below, along with potential trade-offs involved with each. The trade-offs anticipated for randomized designs and the fallback design under consideration should be carefully weighed against each other
when determining the strongest possible design for a given
study.
Research on alternative quasi-experimental designs for
evaluation studies is evolving quickly. The standards articulated here take advantage of the most rigorous research available to date, but we expect that as the field continues to evolve,
additional alternative designs will be identified using the
within-group comparisons strategy.
5.b.iii. Standard: Well-conducted regression discontinuity
designs are second only to random assignment studies in their ability to generate unbiased causal
estimates.
Regression discontinuity designs involve determining who
receives an intervention based on a cutoff score on a
preintervention measure. The cutoff score might be based on
merit or need, or on some other consideration negotiated with
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the other research partners. For example, students with reading scores below the 25th percentile might be assigned to a
tutoring intervention while the remaining students serve as a
control, or communities whose per capita income level falls
below a certain point might be targeted for certain services
while those above the cut-point are not. The regression of
the outcome on the assignment score is used to estimate intervention effects. Intervention effects are inferred by observing
differences in the slopes and/or intercepts of the regression
lines for the different groups. This design provides unbiased
estimates of the treatment effects because, as in randomized
studies, the selection model is completely known.
Cook et al. (2008) analyzed three within-study comparisons contrasting causal estimates from a randomized experiment with those from regression discontinuity studies. The
regression discontinuity design studies produced comparable
causal estimates to the randomized studies at points around the
cutoff point. There are now four further studies in each of
which the authors claim that the regression discontinuity and
experimental results are similar at the cutoff. There is also one
(Wing and Cook 2013) showing that when a pretest comparison function is added to the regular regression discontinuity
(called a Bcomparison regression discontinuity function^), this
mitigates the disadvantages of the regression discontinuity
relative to the experiment. That is, regression discontinuity is
more dependent on knowledge of functional forms, its statistical power is lower, and causal generalization is limited to the
cutoff score (Shadish et al. 2002; Trochim 1984, 2000).
Although Wing and Cook (2013) is the only relevant study
with an experimental benchmark, its results indicate that a
comparison regression discontinuity function can enhance statistical power almost to the level of the experiment, can help
support conclusions about proper functional form that the
nonparametric experiment does not need, and can attain causal
conclusions away from the cutoff (and not just at it) that are
similar to those of the experiment. So adding this particular
comparison to the regression discontinuity function can significantly reduce the limitations of the regression discontinuity design relative to an experiment.
5.b.iv. Standard: For some kinds of large-scale interventions (e.g., policy interventions, changes to public
health law, whole-state interventions) where randomization is not practical or possible, comparison time
series designs can provide unbiased estimates of intervention effects.
Flay et al. (2005) included a standard recommending the
use of interrupted time series designs for large-scale interventions where randomization was not feasible. The logic of this
design is that the effect of an intervention can be judged by
whether it affects the intercept or slope of an outcome that is
repeatedly measured (Greene 1993; Nerlove and Diebold

1990; Shadish et al. 2002). For example, Wagenaar and
Webster (1986) evaluated the effects of Michigan’s mandatory
automobile safety seat law for children under 4 by comparing
the rate of injuries to passengers 0–3 years old for the 4 years
prior to enactment of the law and a year-and-three quarters
after its enactment. Flay et al. (2005) pointed out that these
designs could be strengthened by using comparison series in
locations in which the intervention was not implemented, by
using naturally occurring Breversals^ of polices to test whether
the outcome responds to both reversals and reinstatements of
the policy, and by increasing the number of baseline time
points.
Time series designs with only a single treatment group are
rarely unambiguously interpretable because the effects of the
intervention are often confounded with other events occurring
at the same time.3 Often broad reforms are made in response to
highly publicized, often emotionally laden, incidents. These
incidents may result in numerous reforms that fall into place at
roughly the same time, making it impossible to isolate the
effects of only one of them using time series analysis. This
is why all but one test of the similarity of experimental and
ITS results deals with a comparison time series design rather
than a single group interrupted time series design. Using the
comparison time series design, the same outcome measures
might be collected in a neighboring county or state or (in
studies of school policy reform) in a grade level not affected
by the reform. These designs, if well implemented, provide a
means by which confounding effects due to co-occurring
events can be ruled out. A nascent literature (reviewed in St.
Clair et al. 2014) comparing the estimates from these comparison time series designs with those of randomized designs
suggests that the comparison time series designs produce unbiased estimates of treatment effects (this assumes, of course,
that there are few studies with conflicting results sitting in Bfile
drawers^). Wagenaar and Komro (2013) encourage the use of
these comparison time series designs for research evaluating
public health laws and policies and discuss a number of design
features (e.g., multiple comparison groups and multiple levels
of nested comparisons, reversals, replications, examination of
dose response) that can be used to further enhance these designs. These designs have broad utility for a wide variety of
research needs including establishing theory-based functional
forms of intervention effects over time (e.g., understanding the
diffusion S-curves, tipping point transitions, and decay functions that often characterize effects when going to scale). We
conclude that the comparison time series design, but not the
single group interrupted time series design, can provide a useful alternative to randomized designs.
3
This is not true of a similar design often used to study smaller scale
interventions, primarily in behavioral analysis, the ABA or ABAB design. This design is similar to the time series design used for larger units
except that the timing of the intervention is controlled by the researcher
and therefore not confounded with other events.
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5.b.v. Standard: Non-randomized matched control designs
can rarely be relied on to produce credible results.
They should be used only under the following
conditions:(a) Initial group differences are minimized,
especially by identifying intact comparison groups
that are local to the treatment group and demonstrably heavily overlap with it on at least pretest measures
of the outcome (Cook et al. 2008); (b) the process by
which treatment subjects select into the intervention
group (or are selected into it) is fully known, wellmeasured, and adequately modeled (Diaz and
Handa 2006; Shadish et al. 2008);or (c) the covariates used to model any group differences remaining
after careful comparison group choice lead to no detectable pretest difference between the treatment and
comparison groups in adequately powered tests. To
this last end, it is desirable to explicate the selection
process and use it to choose covariates or, where this
is not possible, to include as many covariates as possible that tie into multiple domains.
Early reviews of within-study comparisons (Glazerman
et al. 2003; Bloom et al. 2005) concluded that estimates of
effects from studies using common strategies for equating
groups (e.g., matching, analysis of covariance, propensity
scoring, selection modeling) are often wrong. A well-known
example is the research on hormone replacement therapy for
women where prior nonrandom trials suggested positive effects but a large randomized trial found harmful effects
(Shumaker et al. 2003). A more recent summary of withinstudy comparisons comes to a slightly more optimistic conclusion about the value of nonrandomized matched comparison group designs. Cook et al. (2008) summarized results
from nine within-study comparisons of random assignment
versus matched comparison groups. Some but not all of these
matched comparison estimates were similar to the estimates
obtained in the randomized arm of the study. Cook et al.
(2008) described the very specific conditions under which
nonrandomized matched designs produce similar results to
randomized designs.
First, studies in which researchers designed the study beforehand to identify an intact comparison group that was
Blikely to overlap with the treatment group on pretest means
and even slopes^ (Cook et al. 2008, p. 736) resulted in comparable experimental and nonexperimental study effect size
estimates. For example, Bloom et al. (2005) evaluated the
National Evaluation of Welfare-to-Work Strategies. One part
of this evaluation reported on five sites in which a comparison
group from a randomized trial conducted in a different job
training center was used as a matched comparison group,
but the comparison training centers were located in the same
state (or the same city in four of the five sites), and the measurement was taken at the same time as the measures for the

subjects in the job training sites that were the focus of the
evaluation. No matching of individual cases was conducted,
but the careful selection of intact groups from similar locations
and times resulted in pretest means and slopes that did not
differ between the treatment and comparison groups.
Conversely, when intervention and comparison sites were
from different states or even different cities within a state,
the groups were not at all equivalent and differences could
not be adjusted away. Cook et al. (2008) concluded that the
use of intact group matching, especially using geographic
proximity as a matching variable, is a useful strategy for reducing initial selection bias.
The second condition under which effects sizes from
nonrandomized matched comparison group designs matched
those from randomized studies involved treatment and
nonrandomized comparison groups that differed at pretest
but where the selection process into treatment was known
and modeled (Diaz and Handa 2006). An example of this type
of study comes from an evaluation of PROGRESA in Mexico.
In this study, eligible villages were randomly assigned to receive the intervention or not, and eligible families in treatment
villages were compared with eligible families in control villages on outcomes. Eligibility for the intervention was based
on scores on a measure of material welfare, both at the village
level and at the individual family level within village. The
design identified villages that were too affluent to be eligible
for PROGRESA. These villages were clearly different than
the villages that participated in PROGRESA, but the selection
mechanism that resulted in some villages and families being
selected into the study and others not was completely known
and measured. Once the same measure of material welfare that
had determined eligibility for PROGRESA was statistically
controlled, selection bias was reduced to essentially zero.
These conditions—intact group matching and complete
knowledge of the selection process—are rare. It is not yet
clear when nonrandomized matched comparison group
designs that do not meet these conditions will yield valid
results, regardless of the technique used for statistical adjustment. However, the likelihood of bias is reduced when
initial group equivalence is inferred from adequately
powered no-difference results on multiple, heterogeneous
baseline measures that include at least one wave of pretest
measures of the main study outcome. This is the criterion
currently advocated by the What Works Clearinghouse of
the Institute for Educational Sciences (http://ies.ed.gov/
ncee/wwc/).
In nonexperimental studies, the choice of data analysis
technique is not very important for reducing selection bias.
Direct comparisons of ordinary least squares and propensity
score matching methods have not shown much of a difference
to date (Glazerman et al. 2003; Bloom et al. 2005; Shadish
et al. 2008; Cook et al. 2009), though the latter is theoretically
preferable because it is nonparametric and requires
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demonstrated overlap between the treatment and comparison
groups on observed variables. More leverage for reducing
selection bias comes from (a) preintervention theoretical analysis of the selection process into treatment—or even direct
observation of this process—so as to know which covariates
to choose, (b) selecting local comparison groups that maximize group overlap before any covariate choice, and (c) using
a heterogeneous and extensive collection of covariates that, at
a minimum, includes one or more pretest waves of the main
study outcome (Cook et al. 2009).
The evidence to date suggests that randomized studies are
less vulnerable to bias than nonrandomized studies, but that
regression discontinuity and comparison time series designs
may be suitable alternatives to randomized studies. However,
it bears repeating that a poorly implemented randomized design is as likely to yield biased results as a nonrandomized
study. Randomization can be subject to tampering. But even
when executed faithfully, randomized trials often suffer from
differential attrition across study groups, which often reduces
group equivalence and renders the study results ambiguous.
Therefore, we caution against any process for identifying efficacious interventions that identifies effective interventions
based on the initial study design without carefully considering
the quality of implementation of the design. We also provide
the following standard to guide reporting of randomization
procedures (above) and analysis and reporting of study
attrition:
5.c. Standard: The extent and patterns of missing data must
be addressed and reported.
Analyses to minimize the possibility that observed effects
are significantly biased by differential patterns of missing data
are essential. Sources of missing data include attrition from the
study, from particular waves of data collection, and failure to
complete particular items or individual measures. Missing data is particularly troubling when the extent and pattern of
missing data differs across experimental conditions.
Differences across conditions in the nature and magnitude of
attrition or other missingness can bias estimates of intervention effects if they are not taken into account. Note that differential measurement attrition can occur even when the rates of
attrition are comparable across groups.
Schafer and Graham (2002) discuss methods of analyzing
data in the face of various kinds of missingness. One common
strategy is to impute missing data based on the data that are
available. Appropriate application of these imputation
methods requires assumptions about the pattern of
missingness, however, and these assumptions are often not
justified in practice. The required assumption is that missing
data are Bmissing at random,^ which means that there is no
discernible pattern to the missingness once measured variables
are controlled. If this assumption cannot be met (as is often the

case), sensitivity tests should be conducted to probe the likely
impact that missing data might have on the estimates of the
intervention effect (Enders 2011; Imai 2009; Muthen et al.
2011).

Statistical Analysis
6.a. Standard: Statistical analysis must be based on the design and should aim to produce a statistically unbiased
estimate of the relative effects of the intervention and a
legitimate statistical statement of confidence in the
results.
6.b. Standard: In testing main effects, the analysis must assess the treatment effect at the level at which randomization took place.
In many contexts in which prevention researchers carry out
their work, the participants belong to naturally occurring
groups that often must be taken into account when conducting
statistical tests. For example, if a researcher is testing a drug
prevention curriculum in third grade classrooms, the fact that
the students belong to the classrooms means those student
responses may not be independent of other students in the
same classroom, and this has an important impact on the validity of the statistical tests. Often, researchers will randomize
at a higher level (e.g., the school) but analyze the data at a
lower level (e.g., individuals). Doing so almost always results
in a violation of the assumption of the statistical independence
of observations. Even small violations of this assumption can
have very large impacts on the standard error of the effect size
estimate (Kenny and Judd 1986; Murray 1998), which in turn
can greatly inflate the type I error rate (e.g., Scariano and
Davenport 1987). In these situations, analysts must conduct
analyses at the level of randomization and must correctly
model the clustering of cases within larger units (Brown
1993; Bryk and Raudenbush 1992; Hedeker et al. 1994;
Zeger et al. 1988). For example, if an intervention is delivered
at the clinic level (e.g., some clinics deliver a new intervention, others do not), then clinics should be randomly assigned
to conditions, and the statistical analyses must take into account that patients are nested within clinics.
6.c. Standard: In testing main effects, the analysis must include all cases assigned to treatment and control conditions (except for attrition—see above).
6.d. Standard: Pretest differences must be measured and
statistically adjusted, if necessary.
That is, when differences between groups on pretest
measures of outcomes or covariates related to outcomes
are observed, models testing intervention effects should
incorporate these pretest values in a manner that adjusts
for the preexisting differences.
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6.e. Standard: When multiple outcomes are analyzed, the
researcher must provide a clear rationale for the treatment of multiple outcomes, paying close attention to the
possibility that conclusions may reflect chance findings.
There is no consensus on the best way to handle this issue
in prevention research. However, an expert panel recently
convened by U.S. Department of Education Institute of
Educational Sciences explored ways of appropriately handling multiple comparisons (Schochet 2007). This panel recommended that outcomes be prioritized to reflect the design of
the intervention and that confirmatory analyses be conducted
to test global hypotheses within the main domains identified
as central to the study’s hypotheses. For example, a program
might include a tutoring component aimed at improving academic performance and a social skills curriculum aimed at
improving social competency skills. Schochet (2007) recommends that multiple measures of academic performance (e.g.,
teacher reports of academic competence, grade point average,
standardized reading, and math scores) be combined into one
scale to test the hypothesis that the program influences academic performance and that multiple measures of social competency (e.g., goal setting, decision-making, and impulsive
control) be combined into a second scale to test the hypothesis
that it influences social competency skills. The report recommends against testing each of the multiple measures as a separate outcome.
Our standard does not require that researchers follow this
advice, but rather that they attend carefully to potential misinterpretations due to the analysis of multiple correlated outcomes and provide a clear rationale for the treatment of multiple outcomes.
Efficacy Claims—Which Outcomes?
7.a. Standard: Results must be reported for every targeted
outcome that has been measured in the efficacy study,
regardless of whether they are positive, nonsignificant,
or negative [Reporting Standard].
7.b. Standard: Efficacy can be claimed only for constructs
with a consistent pattern of nonchance findings in the
desired direction. When efficacy claims are based on
findings from more than one study, efficacy can be
claimed only for constructs for which the average effect
across studies is positive.

Science: To rule out chance findings and to demonstrate that
results obtained in one study are robust to variations in time,
place, and certain implementation factors. The latter are generalizability issues that are most appropriately addressed in
effectiveness trials. Before an intervention can be judged to
be a suitable candidate for effectiveness trials, though, the
possibility that positive results were due to chance must be
minimized.
Flay et al. (2005) called for at least two different studies of
an intervention, each meeting all of the other efficacy standards,
before an intervention could be labeled as Befficacious.^ This
standard is consistent with recent calls in Psychology for more
direct replication studies to rule out chance findings. Pashler
and Harris (2012) note that replication studies that test the same
experimental procedure are extremely rare in psychological
research, but they are essential to the conduct of science.
They calculate that more than a third of published positive
results are likely to be erroneous, even when researchers set
low alpha levels (e.g., .05).4 Further, Bconceptual^ replications,
in which researchers vary aspects of the intervention or the
research operations, do not help to rule out chance findings
because failures to replicate in such studies are too easily attributed to the variations tested rather than to the possibility that the
earlier results were due to chance.
Flay et al. (2005, p. 162) recognized that exact replication
in which the same intervention is tested on Ba new sample
from the same population, delivered in the same way to the
same kinds of people, with the same training, as in the original
study^ is rare, and suggested that Bflexibility may be required
in the application of this standard …until enough time passes
to allow the prevention research enterprise to meet this high
standard.^
Time has passed. The prevention research enterprise appears no closer to reaching this high standard for replication
to rule out chance findings, and funding agencies are no more
likely today to fund replications simply to verify the results of
an earlier study than they were 10 years ago. When replication
studies are conducted, they are much more likely to be for the
purpose of testing variations in the intervention or of generalizing results to different settings or populations than for ruling
out chance findings. Although the accumulation of positive
results from this type of replication study does eventually rule
out chance findings, we regard these studies as generalizability

4

Note first that this standard pertains to constructs rather
than to measures of constructs. For studies reporting findings
for multiple measures of the same construct, an omnibus test
that corrects for alpha inflation must confirm a nonchance
effect in the desired direction (see Standard 6.d.).
This standard can be met either within one study or through
replication. Replication has two main purposes in Prevention

They calculate the rate of erroneous published positive findings in the
field of psychology as follows: Assume the null is true 90 % of the time.
Using alpha=.05 and power=.8, type I error will occur in 4.5 % of studies
(90 % *.05) and correct rejections of the null will occur in 8 % of studies
(10 % *.8). Therefore, the proportion of published positive findings that
are erroneous is 36 % (4.5 %/(4.5 %+8 %)). The calculation is highly
dependent upon the assumption about the percentage of tests conducted
for which the null hypothesis is true. The actual rate of correct nulls in
Prevention Science studies is not known.
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studies most appropriate for interventions that have met all of
the efficacy standards.
How should chance be ruled out at the efficacy stage?
Chance can be ruled out in a single study if the magnitude
of the intervention effect observed in a well-designed and
well-conducted trial is so large that it is extremely unlikely
to have arisen by chance given a true null hypothesis. That is,
highly improbable significance levels lend confidence to the
conclusion that the results are unlikely to be due to chance.
For example, using Pashler and Harris’ (2012) reasoning, significant findings at the .005 level would translate into an actual
error rate of approximately 5 %. Differences of this magnitude
from a single trial should suffice to rule out chance.
When intervention effects from a single efficacy trial are
not large enough to confidently rule out chance, one or more
additional trials are needed. Data from these additional trials,
when combined together with the first trial, must achieve a
sample size large enough to test whether findings for the combined dataset exceed chance levels. Also, in order to rule out
chance at the efficacy level, it is important that all experimental units be exposed to the same intervention rather than to
different variants of the intervention, as is often the case in
subsequent trials of an intervention. As noted by Flay et al.
(2005), efficacy trial replications should be Bexact^ replications (Hunter 2001) in which the same intervention is tested
on a new sample of the same population, delivered in the same
way by the same kinds of people, with the same training, as in
the original study, or Bscientific^ replications (Hunter 2001) in
which all aspects are exactly replicated except that the study
samples comes from similar populations rather than the exact
same population (such as is likely in a multisite evaluation of
an intervention). Judgments about the similarity of the population should be made on the basis of the program developer’s
statement of the range of application of the intervention (see
Standard 2.c.).
7.c. Standard: For an efficacy claim, there must be no serious negative (iatrogenic) effects on important outcomes.

Reporting
8. Standard: Research reports should include the elements
identified in the 2010 CONSORT guideline or a relevant
extension of these guidelines.
Several of the standards articulated above are standards for
reporting about prevention research. For example, Standard
2.a. requires that the intervention Bbe described at a level that
would allow others to implement/replicate it,^ and Efficacy
Standard 7.a. states that Bresults must be reported for every
targeted outcome that has been measured in the efficacy
study.^ Most of the standards pertain to research methods that

should be fully described in reports of the research.
Unfortunately, reporting of interventions tested and the
methods used to evaluate them is often suboptimal, even in
our best journals (Grant et al. 2013), and this often makes it
difficult to judge the quality of the evidence from potentially
important prevention trials. Research reports are often brief,
omitting or inadequately reporting important information.
Incomplete and inaccurate reporting results in underuse of
the research.
Incomplete reporting is a problem in other disciplines as
well. This has led to the development of numerous guidelines
for reporting of research across different fields, the most well
known of which is the Consolidated Standards of Reporting
Trials (CONSORT) guideline, which has been recently updated (Schulz et al. 2010). CONSORT is intended to facilitate
the writing of transparent reports by authors and appraisal of
reports by research consumers. It consists of a checklist of 25
items related to the reporting of methods, including the design,
who the participants were, how the sample was identified,
baseline characteristics of the participants on key variables,
how the sample size was determined, statistical methods used,
participant flow through the study (including attrition analysis), the delivery, uptake, and context of interventions, as well
as subsequent results.
The CONSORT guideline was developed by biomedical
researchers to guide reporting of health-related clinical trials.
It is therefore not broad enough to cover all reporting issues
relevant for reporting of Prevention Science research. An extension of the CONSORT guideline has been proposed to
guide transparent reporting of implementation, including
how intervention implementation is adapted in the trial
(Glasgow and Steiner 2012). Other extensions of the
CONSORT guideline have been tailored to certain types of
research common in Prevention Science (e.g., cluster randomized trials, Campbell et al. 2012). Nevertheless, the available
guidelines are insufficient to cover many types of research in
Prevention Science.
A new CONSORT extension for randomized controlled
trials in social and psychological research is under development (Gardner et al. 2013) and is likely to address many of the
special reporting issues in Prevention Science research
(Mayo-Wilson et al. 2013. Indeed, this effort is addressing
several aspects of intervention research discussed in the earlier
SPR standards of evidence (Flay et al. 2005), such as active
ingredients or mechanisms of interventions, interventions that
operate and outcomes that are analyzed at multiple levels (e.g.,
individual, family, school, community), intervention implementation, the role of context (e.g., effectiveness versus efficacy; site differences in a multisite randomized trials), subgroup analysis, and intervention adaptation. This effort is well
underway, with systematic reviews of guidelines and reporting
practices (Grant et al. 2013), a modified Delphi process, and
formal expert consensus meeting completed (Montgomery
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et al. 2013a; see project website: www.tinyurl.com/consortstudy), and is likely to produce highly relevant reporting
guidelines for Prevention Science. CONSORT guidelines
cover only randomized trials. For nonrandomized designs,
an appropriate reporting guideline should be used, such as
the TREND statement (Des Jarlais et al. 2004) for behavioral
and public health interventions. We note that this guideline
would benefit from updating to reflect advances in causal
designs described in Efficacy Standard 5.b.
We encourage SPR to collaborate in the development of
standards for reporting of randomized controlled trials in social and psychological research and to create a task force, or
join in with other groups, to work on refining these standards
to make them broadly applicable to a wider range of research
designs. As these more specific guidelines become available,
the standard should be changed to reflect their availability.

Standards for Effectiveness
The scope of Prevention Science has expanded in the past
10 years away from simply demonstrating efficaciousness
and toward translation of efficacious practices into wider use
in the population (Spoth et al. 2013). While it remains important to develop and test new prevention approaches, the field
must simultaneously demonstrate that observed outcomes
from efficacious interventions generalize to a wider range of
populations, settings, and times and that these effective interventions can be translated into regular practice in communities
(Glasgow and Steiner 2012).
Effectiveness trials seek to increase the generalizability of
findings from efficacy studies. As noted earlier, study results
can be generalized only to the intervention actually tested, the
process through which it was implemented, the samples (or
populations), the time and settings from which they were
drawn, and the outcomes measured. Most efficacy studies
are limited in terms of generalizability because the intervention tested is one in which the developer has exerted substantial control, the population is often carefully selected to be
amenable to the intervention, and the setting is likely to be
one that is conveniently accessed by the researcher. As such,
efficacy trials tell us little about the effect of the intervention
under Breal-world^ conditions or in Bnatural^ settings (Flay
1986). Efficacy trials also often have small sample sizes and
are thus incapable of demonstrating effectiveness across different population subgroups.
Increasing generalizability of intervention effects is therefore a primary goal of effectiveness trials. This goal is most
often met through one or more replication studies.
Effectiveness trials can also set the stage for later scale-up
efforts by exploring factors that are likely to influence later
intervention adoption, quality implementation, and

sustainability. As recommended by Spoth et al. (2013), we
include desirable standards related to preparing for scale-up
efforts.
1. Standard: To claim effectiveness, studies must meet all of
the conditions of efficacy trials plus the following
standards.

Intervention Description
2. Standard: Manuals and, as appropriate, training and
technical support must be readily available.

Generalizability
3.a. Standard: The degree to which findings are generalizable should be evaluated.
3.b. Standard: The target population and setting as well as
the method for sampling both populations and settings
should be explained in order to make it as clear as
possible how closely the sample represents the specified
populations and settings that define the broad target for
future dissemination (see Efficacy Standard 2.c.).
Settings must be community institutions that are the target for future dissemination [Reporting Standard].
3.c. Standard: The sample should contain a sufficient number of cases from each of the dimensions across which
intervention effects are to be generalized to assess intervention effects in each subgroup.
Effectiveness seeks to answer the question: Are positive
effects observed in efficacy trials robust to the variations in
the intervention, populations, time, settings, and outcomes
measured that are likely to be encountered when the intervention is implemented more broadly than it was in the efficacy
trial? The first step in answering this question is to specify the
most important dimensions across which the intervention effects should be generalized. This determination should be
made during the intervention development stage. A clear
statement of Bfor whom^ and Bunder what conditions^ the
intervention is expected to be effective should guide decisions
about the most important population groups, settings, outcomes, and variations in intervention to be tested (see
Efficacy Standard 2.c.).
In order to test robustness across different dimensions, it is
important to collect data that include a sufficient number of
cases from each important dimension. This allows for sufficient statistical power to test for differences across these dimensions. Ideally, the sample would be a random sample from
the population to which the intervention effects are to be generalized, stratified by the important dimensions identified for
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generalizability testing. However, probability samples (at least
of individuals) are rarely used in Prevention Science because
tests of interventions generally require that the subjects be
located in a limited geographical area. Purposive samples including sufficient variability on the important dimensions are
more feasible, but such samples must be carefully described
so that their characteristics can be compared with those of the
intended population. As was recommended in describing the
sample and sampling methods for efficacy trials, we recommend that the CONSORT guidelines be used for reporting
these aspects of the study.
Below we provide standards for testing intervention robustness across specific dimensions that are most likely to be
important for generalizability: population subgroups, variations in intervention, and measured outcomes.5

Population Subgroups
Population subgroups are often defined by membership in a
category defined by gender, race or ethnicity, social class, or
risk level. For large-scale interventions targeting entire populations, important subgroups may include types of communities (e.g., urban, suburban, rural) or types of institutions (e.g.,
alternative schools, regular schools).
4. Standard: Statistical analysis of subgroup effects must be
conducted for each important subgroup to which intervention effects are generalized.
Demonstration of robust effects across important population subgroups can be accomplished by testing for group differences within a single study that has sufficient power to
support such tests, or by testing for significant intervention
effects in separate studies containing samples that are homogeneous with respect to the dimension. In the former, statistical tests should demonstrate that group differences in the intervention effect do not exceed chance levels. If they do exceed chance levels, subgroup analyses should be conducted to
identify the source and nature of the differences. Additional
guidance on subgroup analysis in Prevention Science is provided in Supplee et al. (2013).
Desirable standard: Statistical analyses testing group
differences in the causal mechanisms should be provided
5

Establishing generalizability across time (e.g., do observed effects of
Head Start programs tested in the 1980s generalize to Head Start programs operating decades later?) and settings (e.g., do effects observed for
Life Skills Training observed in public schools generalize to alternative
schools?) may also be important. If the statement of Bfor whom^ and
Bunder what conditions^ the intervention is expected to be effective
(see Efficacy Standard 2.c.) includes specific times and settings, generalizability across these dimensions should also be tested.

if such differences have been proposed in the theory of the
intervention (see Efficacy Standard 2.b.).
Some intervention theories predict that the intervention will
operate differently for different subgroups, or that the intervention must be varied in order to achieve similar effects
across different population subgroups. Planned variations in
the intervention to enhance effectiveness within a specific
population are best treated as new interventions and tested
using the standards for efficacy described earlier. Tests of differing causal mechanisms can be conducted as part of effectiveness trials if they are specified in advance and if the relevant mediating variables have been measured.
The same limitations discussed in the efficacy section for
testing causal mechanism (see Standard 4) apply here. These
tests are not likely to yield definitive results but can at least
provide information about group differences in proposed mediators that are both responsive to the intervention and correlated with the outcomes. Such information can be useful in
guiding efforts to refine the intervention to improve effectiveness across groups.
Intervention Tested
5.a. Standard: The intervention should be delivered under
the same types of conditions as one would expect in
the community institutions where such interventions
are most likely to be situated during scale-up (e.g., by
teachers rather than research staff).
5.b. Standard: It is essential to compare the fidelity and
quality of implementation/delivery of the core components of the intervention to that achieved in efficacy
trials.
Examination of robustness to variation in implementation
quality is important in effectiveness trials because they are
expected to have greater variation than in efficacy trials. It is
important to generate data from these trials about the extent to
which weaker implementation quality diminishes effects and
to understand the extent to which modifications applied in the
field influence outcomes. This information will be critical as
the intervention is scaled up (Glasgow and Steiner 2012). The
level of fidelity and quality achieved in efficacy trials is a
useful benchmark against which to compare such data from
effectiveness trials.
5.c. Standard: The recruitment, acceptance, compliance,
adherence, and/or involvement of the target audience
and subgroups of interest in the core intervention activities should be measured and reported.
Consistent with the goal of effectiveness trials to probe
generalizability across population subgroups, an emphasis
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on subgroup analysis has been added to this standard. Data on
subgroup differences in the take-up of an intervention will
help to explain any observed differences in the effectiveness
of the intervention for these groups.
5.d. Standard: Local adaptations to core components should
be measured and reported.
Local adaptations are modifications made by implementing
organizations and communities that are not part of the intervention as described by the developer. Treatment of such adaptations is discussed at greater length in the section on scaleup efforts.
5.e. Standard: Factors related to the fidelity and quality of
implementation should be measured and reported.
This standard, identified as desirable during the efficacy trial period, is essential at the effectiveness trial stage.
To repeat, factors related to the quality of implementation
include features of the intervention such as amount and
type of training and technical assistance available and
clarity of the intervention materials, characteristics of the
organization adopting the intervention, the type of setting
in which the intervention is tested, and external (social,
economic, and political) forces in the larger community.
Local adaptations are often made to interventions at the
effectiveness stage in an attempt to increase adoption or
implementation. Such adaptations should be documented
(see above) and the effects of the adaptations on implementation fidelity should be noted (Allen et al. 2012).
Effectiveness trials are likely to include meaningful variation on at least some of these potentially important factors. Interpretations of correlational analyses relating these
factors to levels of implementation fidelity and quality are
likely to be ambiguous because factors related to the quality of implementation are likely to be related to other
important predictors of the outcomes, and these differences often remain uncontrolled in analysis. Such analyses can nevertheless provide information about factors
related to variability in implementation fidelity and quality that will be valuable during scale-up efforts. Similar
analyses of the association between these factors and
study outcomes may also be helpful, despite inherent ambiguities in interpretation.
5.f. Standard: Convincing evidence that effects are not biased by investigator allegiance should be provided.
Desirable Standard: In at least one effectiveness trial
demonstrating desired outcomes, a researcher who is
neither a current nor past member of the program developer’s team should conduct data collection and analysis.

One of the most important features of the intervention
trial that must be tested for bias and generalizability is the
involvement of the developer of the intervention. There is
a continuum of developer control over intervention implementation and research. In early stages of testing, the
developer’s team generally controls intervention materials, training, staff selection and supervision, feedback
on implementation, data collection, and data analysis.
During effectiveness trials, developer control over staff
selection and supervision and (sometimes) training and
quality control is loosened. Many prevention scientists
believe that before an intervention is judged to be ready
for scaling up, control over data collection and analysis
should also be passed to an independent investigator.
Flay et al. (2005) stated that Bit is desirable eventually to
have some effectiveness trials that do not involve the developer—to establish whether interventions are sustained and
still effective when the developer is not involved^ (p. 162).
This standard is seldom met in Prevention Science, even
though such studies are clearly feasible. Several independent
evaluations have yielded results similar to those reported by
the developer (see, for example, Gardner et al. (2006) and
Hutchings et al. (2007) as well as the Menting et al. (2013)
systematic review of Incredible Years trials that reported no
effect of developer involvement on the effect size). On the
other hand, the past decade has also witnessed a disturbingly
high rate of failures to replicate when independent evaluation
teams conduct studies of prevention interventions and practices that had met all criteria for effectiveness.6
This challenge has been recognized more broadly in the
social sciences. Pashler and Wagenmakers (2012)) reported
on the status of replication in psychological science. A review of psychological research published in psychology
journals with the highest 5-year impact factors showed that
the percentage of findings that are replicated varied remarkably depending upon whether the replication research team
was the original research team or not. Nearly all findings
(92 %) from the original research team replicated, compared with 65 % from an independent team (Makel et al.
2012). Similarly, Petrosino and Soydan (2005) reported on
results from a review of randomized field trials in criminology and criminal justice. They reported that effect sizes
from trials conducted by program developers/creators were
6

Among the interventions for which at least one study conducted by an
independent evaluator has failed to replicate findings reported by the
developer are: Alert (Ringwalt et al. 2010); Multi-Systemic Therapy
(Centre for Children and Families in the Justice System 2006; Löfholm
et al. 2009); PATHS (Social and Character Development Research
Consortium 2010); Quantum Opportunities (Schirm et al. 2006);
Reconnecting Youth (Hallfors et al. 2006); Strengthening Families
Program (Gottfredson et al. 2006; Gutman et al. 2004); Toward no
Drug Abuse (Rohrbach et al. 2010); and Triple P (Malti et al. 2011).
Note that for some of these interventions, independent evaluations have
also found positive effects.
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more than twice the size of effect sizes from trials conducted by others.
The reason for this pattern of findings is not clear.
Nosek et al. (2012) summarized research that documented
a number of common practices7 researchers engage in
that, although sometimes justifiable, are known to increase the proportion of false results. These practices
may be more common among original research team
members and those with high allegiance to this team, for
whom the desire to replicate is likely to be strongest
(Ioannidis 2012). Of course, the observed pattern of more
positive findings from research conducted by original research teams is equally consistent with a fidelity explanation: Program developers are likely to understand their
interventions better and be more attuned to variations in
implementation quality that might diminish intervention
effectiveness. They are likely to attend more and demand
higher adherence to intervention fidelity standards.
Unless they can rule out investigator allegiance as a factor
contributing to higher effect sizes, designer-controlled programs of research will be weakened with respect to the effect
sizes that might be expected in real-world applications when
the developer is absent. We have therefore added a standard
that requires that evidence be presented before scaling up that
effects are not biased by investigator allegiance.
The most straightforward ways to rule out designer effects
are through replication of positive outcomes by an independent research team or, ideally, through evidence from metaanalysis that developer involvement is not related to effect size
across multiple studies. However, requiring independent replication prior to scale-up at present would severely limit the
number of interventions available for scaling up because so
few have met this high bar. This requirement would add additional time to the already lengthy time needed to for establishing the efficacy and subsequent effectiveness of evidencebased prevention interventions, which can involve a decade or
more of development and evaluation. The challenge is one of
weighing the realities of what is needed to test a preventive
intervention with the need to move effective practices into
routine practice. The goal should be to maximize scientific
7
These practices include, B(a) leveraging chance by running many lowpowered studies, rather than a few high-powered ones; (b) uncritically
dismissing Bfailed^ studies as pilot tests or because of methodological
flaws but uncritically accepting Bsuccessful^ studies as methodologically
sound; (c) selectively reporting studies with positive results and not studies with negative results or selectively reporting Bclean^ results; (d) stopping data collection as soon as a reliable effect is obtained; (e) continuing
data collection until a reliable effect is obtained; (f) including multiple
independent or dependent variables and reporting the subset that
Bworked;^ (g) maintaining flexibility in design and analytic models, including the attempt of a variety of data exclusion or transformation
methods, and reporting a subset; (h) reporting a discovery as if it had
been the result of a confirmatory test, and; (i) once a reliable effect is
obtained, not doing a direct replication^ (Nosek et al. 2012, p. 618).

rigor in establishing their efficacy and effectiveness while also
reducing the time needed to establish their readiness for dissemination and implementation.
The goal of making independent evaluations of preventive
interventions routine is arguably too distant at this time to
justify establishing a requirement that these evaluations be
completed prior to scaling up. Instead, we hope to elevate
awareness of the issue of investigator allegiance and to suggest that addressing this issue will increase the scientific integrity and credibility of our field. Our standard instead requires attention to the issue of investigator allegiance and a
discussion of the steps that have been taken to minimize it,
adjust for it, or bracket its potential effects. We also include
independent replication as a desirable standard in the near
term while the field builds consensus about this issue as well
as the capacity to more routinely carry out these evaluations.
We hope to encourage developers to move toward partnering
with different research teams to conduct independent evaluations of their programs and to attune funding agencies to the
importance of these endeavors. We anticipate that this desirable standard can become a required standard in the future.
Outcomes Measured
6.a. Standard: To be considered effective, the effects of an
intervention must be practically important. Evaluation
reports should report evidence of practical importance.
The standards for efficacy require only that a plausible
argument be presented for why the intervention has the potential to affect outcomes that have practical significance in terms
of public health impact. Such information is critical at the
effectiveness trial stage because it will influence decisions to
adopt the intervention later. Assessing multiple outcomes that
are likely to tap into the priorities of different audiences makes
research more likely to be translated into practice (Glasgow
and Steiner 2012). Therefore, effectiveness trials must collect
data on and report results for outcomes that would be considered important to the broader community that would be served
by such interventions (e.g., crimes committed, high school
graduation and employment rates, reports of child maltreatment, health outcomes). Note that these outcomes may include intermediate outcomes (e.g., hypertension, obesity,
physical inactivity, diabetes as risk factors for cardiovascular
disease) when such intermediate outcomes are widely accepted, based on empirical evidence that they are major risk factors for the subsequent outcome. Such empirically supported
intermediate outcomes are commonly accepted as meaningful
in public health research and can be applied productively to
assess the effectiveness of interventions for the prevention of
behavioral health outcomes.
As a general rule, the practical significance of the outcome
can be expressed in terms of the combination of strength of
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effect and size of population affected. However, metrics of
practical significance are likely to differ depending on the
nature of the EBI. For EBIs targeting individuals or relatively
small aggregates such as families, it is customary to use effect
size calculations. EBIs that target entire populations may produce outcomes of practical significance even if the magnitude
of the effect on individuals is small. These complexities need
to be considered when describing the practical significance of
the outcome.
6.b. Standard: Cost-effectiveness information should be
reported.
This standard, identified as desirable in the efficacy stage,
is elevated to a standard at the effectiveness stage because this
information will be necessary before scale-up efforts are undertaken (Glasgow and Steiner 2012). See earlier discussion
regarding cost elements (Efficacy Standard 3.c.).
Desirable Standard: It is desirable to report cost-benefit
information.
Cost-benefit analysis assigns a monetary value to the measure of effectiveness and compares the cost of the intervention
to the savings achieved through its implementation. For example, a preschool program may produce large benefits to
society through later crime reduction. Although this information on longer term benefits of prevention interventions is
seldom available, such information would likely to be a powerful tool at the adoption and sustaining stages of scale-up.
Effectiveness Claims
7. Standard: Effectiveness can be claimed only for intervention conditions, populations, times, settings, and outcome
constructs for which the average effect across all effectiveness studies is positive and for which no reliable iatrogenic effect on an important outcome has been
observed.
This standard requires summarizing outcomes across available effectiveness studies. The earlier SPR standards required
that effectiveness could be claimed only for outcomes for
which there are Bsimilar effect sizes in the preponderance of
evidence from effectiveness trials^ (Flay et al. 2005, p. 166).
We believe that most policymakers care more that the intervention will produce a positive effect on an outcome of practical importance than they do about the exact magnitude of the
effect. It is also less likely that different trials will produce
similar effect sizes than that they will replicate a positive effect
on an outcome.
Consistent with the recommendations of a recent SPR
task force on replication in Prevention Science (Valentine

et al. 2011), we recommend that data synthesis techniques,
including meta-analysis or analysis of combined
individual-level datasets, be used to characterize the average effect across effectiveness studies, and that effectiveness be claimed only for those outcome constructs for
which the average effect size across all tests of that construct be in the positive direction, and that any outcome
construct in the undesired direction can be attributed to
chance. Only studies that have been carried out in Brealworld^ conditions (e.g., conditions that match the intended
target for future dissemination—see Efficacy Standard
2.c.) should be included in this average. Such a pattern of
findings supports a claim of effectiveness.
It is also important to characterize the extent to which
the effectiveness claim is robust to the variations in intervention conditions, population characteristics, settings,
and times that have been tested. An effectiveness claim
for a subgroup, setting, or intervention condition can be
supported by either showing that the overall positive outcome does not differ significantly across these conditions
(e.g., by reporting a nonsignificant homogeneity statistic
in a meta-analysis), or by showing that the average effect
size for each condition is positive with no reliable iatrogenic effects on important outcomes.
As Prevention Science advances and more studies of specific EBIs become available, the importance of data synthesis
across studies will become more critical in establishing effectiveness. Although models are available (Perrino et al. 2013),
agreed-upon structures and mechanisms to facilitate the sharing of individual-level datasets for combination and data synthesis do not currently exist. We encourage SPR to create a
task force to work on developing standards to guide the sharing of individual-level datasets for combination and data
synthesis.
Research to Inform Scale-up Efforts
Relatively little rigorous research has been conducted related to the processes and systems through which EBIs are
adopted, implemented, and sustained on a large scale.
Spoth et al. (2013) lay out an ambitious agenda for research to inform scale-up efforts. Scholars of dissemination and implementation research recommend that activities be undertaken throughout the planning, development,
and evaluation of an intervention to increase its dissemination and implementation potential (Rabin and Brownson
2012). Spoth et al. (2013) also argue that it is important
to embed research on these important questions into effectiveness trials of the EBIs so that essential information is
available to guide later scale-up efforts. Below we list several research questions, mostly identified by Spoth et al.
(2013), that we believe can be most feasibly studied in
ongoing effectiveness trials of a particular EBI.
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Research on factors influencing adoption decisions:
&
&
&
&
&

What are the channels of information through which
stakeholders learn about the EBI?
What are the key market, organizational, and other factors
influencing adoption decisions?
What are the incentives/disincentives for EBI adoption by
various stakeholders?
What decision-making tools do stakeholders use in
selecting an EBI?
How are cost and other economic data used in the decision
to adopt an EBI?
Research on implementation fidelity and quality:

&
&
&
&
&
&
&
&

What are the characteristics of providers who are most
likely to implement the EBI?
What aspects of implementation fidelity and quality are
related to outcomes?
What are the most effective delivery systems for the EBI
in different settings?
What are the effects of different training and technical
assistance methods on implementation fidelity and
quality?
How do amount, type, and mode of delivery of training
and technical assistance affect implementation quality?
What are the key factors that influence participation in
EBIs? And what are the best strategies for enhancing
participation?
What are the relative contributions of EBI core components and how do specific adaptations affect outcomes?
What is the cost of implementing the intervention?
Research on sustainability:

&
&
&

What management, motivation, organization, training,
and technical assistance factors for organizations and
communities lead to greater sustainability?
What funding models and financing strategies are most
conducive to sustainability?
What policies are most conducive to stable funding
streams?

Research on these features might involve descriptive research on consumer preferences carried out during the site
recruitment phase or during implementation. It might also
involve examining how natural variation in characteristics of
interventions or communities varies with intervention implementation quality. For example, a study might examine differences in implementation quality by potentially important intervention features (e.g., delivery agents, training quantity) or
by measures of community capacity (although interpretation
of findings would have to recognize that such associations are

likely to be confounded with other important predictors of
implementation quality). Stronger tests of moderating effects
of intervention features could be obtained by embedding a
study to test the effect of deliberate manipulation of the intervention feature on measures of implementation quality or sustainability. For example, effectiveness trials might randomly
assign units to different levels of training and technical assistance, to different levels of organization development assistance, to different intervention delivery agents (e.g., nurses
versus nurse practitioners; peers versus teachers), or different
modes of delivery (e.g., online training or in-person training).
Clearly, much research is needed to support the translation
of EBIs into broader use. We agree that effectiveness research
represents an important opportunity to address these questions. In addition to the required standard for reporting on
factors related to implementation quality in effectiveness trials
(Effectiveness Standard 5.e.), we offer the following desirable
standard promoting research on factors related to adoption,
implementation, and sustainability of EBIs:
Desirable Standard: It is desirable in effectiveness trials
to investigate the context, systems, and other factors that
influence intervention adoption, quality implementation,
and sustainability of the EBI.

Standards for Scaling Up of Evidence-Based
Interventions
Much attention has been directed in the past decade toward
challenges confronted in the scale-up of prevention interventions. This scale-up process entails translation of interventions that have been demonstrated to be effective when
tested on a limited scale into standard practice on a broad
(population-level) scale. The goal of such scale-up efforts is
to achieve population impacts on important outcomes
through sustained, high-quality implementation of EBIs.
Reaching this goal requires awareness of the multiple factors that influence intervention implementation in natural
contexts. Successful implementation requires careful attention to a wide range of factors that can influence the quality
and sustainability of the implementation. It depends upon
the confluence of features of the intervention, characteristics of the organization adopting the intervention, and external (social, economic, and political) forces in the larger
community (Fixsen et al. 2005).
A recent report from an SPR task force on type 2 translational research (Spoth et al. 2013), while recognizing that this
new Btranslation science^ is still in its infancy, offered a
framework for thinking about the phases of translation from
research to practice, summarized research related to these different phases, and set ambitious agendas for both practice
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(e.g., building community infrastructures to support scale-up
of evidence-based practices) and research to advance the science of translation.
Spoth et al. (2013) described activities, strategies, and processes concerning four phases of translational functions:
&
&
&
&

Preadoption phase: addressing intervention, consumer,
provider, and organizational characteristics with scale-up
feasibility assessments or dissemination/marketing plans
Adoption phase: attending to adoption decision-making
factors and processes
Implementation phase: integrating quality implementation
procedures and processes into service systems or settings
Sustainability phase: institutionalizing or maintaining
over the long term and expanding reach

They summarized research on the features of both the intervention and the adopting organizations and communities
that appear related to successful outcomes at each phase.
Noting the paucity of research on most of these features, they
identified research questions that still need to be answered in
order to advance a science of translation, and they discussed a
variety of research designs and methods that might be applied
to answer these questions. They also noted that little rigorous
research has been conducted to assess the outcomes of scaleup efforts.
The work of this SPR task force on type 2 translational
research provides a useful framework for refining the SPR
standards of evidence related to the scaling up of EBIs. The
earlier standards (Flay et al. 2005) recognized that successful
dissemination was a function of a complex interplay between
the intervention developer and the adopting community, and
identified key features of an intervention that needed to be in
place in order to increase the likelihood that typical service
providers or others could implement it effectively. Below we
elaborate on these features, incorporating findings from recent
research on features of interventions that are related to successful adoption, implementation, and sustained implementation of EBIs.
In addition to attending to these features of interventions, it
is necessary to create a strong organizational and community
infrastructure for translational success. An intervention may
be ready to be scaled up in terms of the research supporting its
effectiveness and (if appropriate) the materials, training, and
technical assistance available to communities, but it will not
be adopted, implemented, or sustained in the absence of local
capacity to adopt, implement, and sustain its use. The scientific research base for understanding the most important features of organizations and communities that predict their success in adopting, implementing, and sustaining evidencebased practices is not as well developed as is the research on
features of interventions that promote these same outcomes,
but enough consensus exists to provide a basis for establishing

preliminary standards for practice related to community and
organizational infrastructure (Aarons et al. 2012; Spoth et al.
2013). We anticipate that the work of the SPR task force on
type 2 translational research will encourage new research to
further clarify important organizational factors that can later
be incorporated into a refined set of standards to guide organizations and communities in developing capacity to adopt,
implement, and sustain effective interventions.
The literature on characteristics of adopting organizations
and communities is far reaching. Some of this work has implications for actions at the federal and state levels to improve
community capacity for adopting, implementing, and sustaining EBIs. We stopped short of incorporating standards related to
efforts to improve capacity in general (such as improving dissemination of knowledge about EBIs or creating funding structures) because the scope of our work is more narrowly defined.
Our objective is to update the earlier effort to Bdetermine the
most appropriate criteria for prevention programs and policies
to be judged efficacious, effective, or ready for dissemination^
(Flay et al. 2005, p. 152). We defined efforts to assess organizational or community readiness for adoption of a particular
EBI, to encourage high-quality implementation, and to prepare
organizations or communities for sustained high-quality delivery of particular EBIs as within our scope, while more general
activities that are not directly connected to particular EBIs were
defined as outside of our scope.
Readiness for Scaling Up EBIs
The standards regarding readiness for scaling up are not standards of Bevidence^ in the sense used elsewhere in this document. The standards provided to guide efficacy and effectiveness trials pertained to the features of the research evidence
that are required in order to label an intervention as efficacious
or effective. The standards described below are features of the
intervention or of the organization or community adopting the
intervention rather than of the evidence about the consequences of implementing the intervention. These features of
interventions or environments have been shown to be related
to adoption, implementation, or sustainability of the intervention. These standards are intended to provide practical guidance to scale-up efforts.
Four recent reviews summarize much of the relevant research on the characteristics of interventions and environments that are related to high-quality delivery of EBIs.
Durlak and DuPre (2008) summarized findings from 81 studies of prevention and health promotion for children and
adolescents that contained data on factors affecting the
implementation process. Fixsen et al. (2005) reviewed studies
concerning implementation from a much broader set of domains (including agriculture, business, child welfare, engineering, health, juvenile justice, manufacturing, medicine,
mental health, nursing, and social services). They located
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377 Bsignificant implementation^ articles, 22 of which reported
the results of experimental analyses or meta-analyses of implementation variables. A recent volume on dissemination and
implementation research in health (Brownson et al. 2012 and
especially a chapter in that edited volume on the role of organizations in that process (Aarons et al. 2012) and the Spoth
et al. (2013) review described earlier provide comprehensive
reviews of the most recent research on factors related to adoption, implementation quality, and sustainability of EBIs. Note
that the existing literature on characteristics related to highquality delivery of EBIs focuses mainly on smaller scale interventions that usually involve education or provision of other
services. The standards reflecting this evidence base therefore
include a disproportionate focus on characteristics of service
providers, materials, training, and technical assistance. The
characteristics related to high-quality implementation of larger
scale EBIs such as laws or broad policies are not as well documented but are likely to involve some of these same activities.
1. Standard: Only EBIs that have met all effectiveness
criteria should be made available for scaling up.

Preadoption and Adoption Phases Several of the activities
recommended by Spoth et al. (2013) aimed at encouraging
adoption of EBIs are community-level supports and practices
that occur well-before a particular EBI has been identified.
Decisions about how best to make information about EBIs
available to a community and the establishment of epidemiological data sources to guide community decision-making
about which EBIs would suit the needs of the community are
outside of the scope of our work (see above). Here we provide
guidance on three activities that can be undertaken with respect
to a particular EBI: assessing community readiness for the EBI,
embedding the EBI in an appropriate organization development intervention to strengthen community capacity, and providing clear information about the costs of the EBI.
Desirable Standard: Prior to scaling up, it is desirable to
conduct an assessment of factors that are likely to impede
or facilitate adoption and successful implementation of
the EBI and the capacity of the community or organization to implement the EBI in a high-quality fashion. This
assessment can use an available psychometrically sound
community assessment tool, or it can take the form of
original research to describe local conditions that are
likely to influence adoption, implementation, and sustainability. The results of the assessment should be utilized in
planning efforts during the adoption phase.

There is general consensus that an assessment of the organization or community’s capacity to implement EBIs in a

high-quality fashion, conducted prior to the decision to adopt,
would be helpful for uncovering likely obstacles to implementation that could be addressed prior to adoption or for identifying strengths that could improve implementation (Spoth
et al. 2013). Aarons et al. (2012) summarize research on characteristics of organizations that increase their likelihood of
adopting and implementing EBIs. Among the most important
characteristics that encourage a climate supportive of
implementing EBIs is the presence of a strong leader who
communicates a vision that includes the use of evidence to
guide practice and encourages adherence to that vision. Such
leadership encourages positive attitudes toward adopting EBIs
(Aarons et al. 2012). Prior to scaling up an intervention, an
assessment of factors such as the leadership potential in the
community should be undertaken.
Fixsen et al. (2005) reviewed several available scales designed to measure different aspects of community readiness to
implement EBIs, including attitudes about EBIs, motivational
readiness, community resources, staff attributes, organizational climate, and stages of community readiness. Although good
psychometric properties have been reported for these scales,
we know of no rigorous research that has tested the validity of
the scales for predicting improved implementation quality or
sustainability of an intervention.
Related to community readiness assessment is the recommendation that Bpractice-oriented research^ can help to
enhance community conditions conducive to adoption,
implementation, and sustained use of EBIs (Spoth et al.
2013). This type of research is highly collaborative and
focused on answering practical questions. Such research,
conducted early in a scale-up effort, could provide invaluable information about the local context, culture, decisionmaking processes, and history that could guide local adaptations of noncore aspects of the intervention and help
with planning to remove likely barriers to recruitment,
acceptance, participation, and high-quality implementation. Such research, tailored to the specific community,
could serve the same purpose as a more formal community readiness assessment.
We suggest that the use of some form of community readiness assessment is desirable, assuming predictive validity can
be established. At present, very little research is available to
guide the use of data from such assessments in practice. That
is, although interventions are currently being developed and
tested to encourage readiness factors such as strong leaders
(Aarons et al. 2012), much research is needed in this area. We
anticipate that future research will provide clearer evidence of
the value of such assessments.
Desirable Standard: It is desirable for the scale-up effort
to be implemented in the context of an organization development intervention to support the adoption, implementation, and sustained use of an EBI.

Prev Sci

This standard recognizes that characteristics of the community organization(s) adopting the EBI are likely to be at least as
important as characteristics of the intervention in determining
success. Often, preliminary efforts are required to shore up
community infrastructure to increase the likelihood that the
intervention will be implemented in a high-quality fashion
and sustained over time. Emerging research suggests that
EBIs of the future should include an organization
development component to increase its adoption,
implementation, and sustainability. For example, Glisson
et al. (2010) demonstrated in a randomized trial that
multisystemic therapy (MST) is more effective when implemented in the context of an organization development intervention that focuses on improving leadership and community
agency culture and climate than when MST is implemented
alone.
Community partnership models are another form of
organizational development intervention that have been
shown to enhance selection, adoption, and sustained use
of EBIs (Fagan et al. 2009; Spoth et al. 2011; Spoth
and Greenberg 2011). This research has demonstrated
the success of two different models of community partnerships/coalitions, both of which draw upon existing
community resources and involve a high degree of community input in decision-making about the selection and
implementation of EBIs. Because the community factors
influencing sustainability of EBIs are likely to be dynamic, the model used to develop community infrastructure needs to incorporate continuous assessment of the
local context and ongoing decision-making to maintain
the match between the EBI and the community
(Chambers et al. 2013).
2. Standard: Clear cost information and cost tracking and
analysis tools that facilitate reasonably accurate cost projections and are practically feasible must be made available to potential implementers.
Providing clear cost information was identified as a standard beginning at the efficacy stage. Such information should
be refined throughout the testing of the EBI so that it provides
an accurate estimate of the cost of the intervention as delivered
at scale, under natural conditions of service implementation
by community settings. Spoth et al. (2013) suggest that cost
tracking and analysis tools that facilitate reasonably accurate
cost projections and are practically feasible be made available
to communities. As noted earlier, standards do not currently
exist to guide decisions about which cost elements should be
included in cost accounting. Recommendations from an
Institute of Medicine workshop and an SPR task force should
be available soon. In the meantime, we recommend that the
cost elements discussed under Efficacy Standard 3.c. be
included.

Implementation Phase Flay et al. (2005) discussed standards related to the materials, training, and technical support
that must be in place before an intervention is ready to be
taken to scale. Since these standards were articulated, additional research has clarified which aspects of these materials,
training, and technical assistance appear most critical to ensuring adoption, high-quality implementation, and sustainability. We therefore offer refinements to these initial standards to better align them with current research findings.
Materials
3. Standard: To be ready for scaling up, materials that specify the activities to be carried out and optimal methods of
delivery must be available. Materials should include a
clear statement of the conditions necessary to implement
the intervention, including characteristics of the setting,
and qualifications of intervention providers. If appropriate, standardized audiovisual aids, reproducible materials, and lists of materials needed should be included.
Some interventions do not involve materials. For interventions that do, research recommends the use of manuals that
include reproducible materials, provide audiovisual aids, provide lists of materials to be used, and specify activities to be
carried out because such materials are related to higher scores
on measures of implementation quality than interventions
lacking such structured materials (Gottfredson and
Gottfredson 2002). Interventions that are attractively packaged and easy to use and that utilize teaching methods familiar
to the provider are also more likely to be adopted and implemented (Rohrbach et al. 2006). Intervention materials that
include a clear statement of the conditions necessary to implement the intervention, including characteristics of the setting,
qualifications of intervention providers, content, and methods
are also more likely than less explicit materials to be implemented with higher quality (Fixsen et al. 2005). These findings suggest that standardization and structure are important
features of intervention materials.
The findings summarized in Durlak and Dupre (2008),
however, suggest that adaptability and flexibility are key
features of the intervention related to implementation
quality. An adaptable intervention is one that can be
modified to fit the needs of the organization and community
potentially implementing the intervention. Rabin and
Brownson (2012) identify reinvention or adaptation as essential to the success of dissemination and implementation efforts
and suggest that such adaptation is likely to lead to Bat least
equal intervention effects as shown in the original efficacy or
effectiveness trial^ (p. 35).
Durlak and Dupre (2008) note the apparent contradiction
between the importance of fidelity and adaptability in the research on implementation quantity and suggest that the
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apparent contradiction is resolved by recognizing that both
qualities can coexist in an intervention. The challenge is to
find the right mix of standardization and adaptability that
maintains the integrity of the intervention while allowing for
flexibility at the local level concerning adaptability to conditions. How to do this is a challenge that is currently the subject
of debate and research in the prevention field (see, for example, the ongoing study by the CDC Foundation to learn how
community-based organizations adapt EBIs and whether or
not those adaptations make the interventions more or less
effective; CDC Foundation 2013). Until more definitive information is available to guide this process, we propose
(consistent with Rabin and Brownson 2012) that intervention
developers provide a clear statement about what aspects of the
intervention are considered core components that cannot be
altered, and which are more flexible. Standards related to the
description of the intervention have been revised to require
identification of core components (Efficacy Standard 2.d.),
and a new standard has been added to encourage testing of
core intervention components (Efficacy Standard 4).
Training and Technical Assistance
4.a. Standard: To be ready for scaling up, training for
implementing the core components of the intervention
must be available. This training must include demonstration of the new practices, ample opportunity for
practicing the new skills, and feedback on performance
of the new skills. A clear statement concerning which
aspects of the intervention can be locally adapted
should be included in the training. The training should
be consistent with the level of training that was found to
produce high-quality implementation in effectiveness
trials (see Effectiveness Standard 5.e.).
4.b. Standard: To be ready for scaling up, technical assistance must be available for the EBI. This technical assistance must be proactive and must provide ongoing
support for additional teaching while the practitioner
is engaged in practice activities, direct assessment and
feedback on performance, and emotional support.
While much of the research on the provision of technical
assistance concerns interventions involving direct services, it
is likely that high-quality implementation of larger scale interventions such as passage of new laws or changes to broad
policies often requires some type of technical assistance to
those charged with implementing the changes. The nature of
the technical assistance is likely to differ depending on the
type of intervention. Research on training and technical assistance suggests that although initial training is usually required
to provide knowledge about the intervention, training by itself
seldom improves the quality of implementation (Fixsen et al.
2005). Training that provides information only and Bone-shot^

training with no follow-up are especially unlikely to produce
high-quality implementation. However, training that includes
demonstration of the new practices, ample opportunity for
practicing the new skills, and feedback on performance of the
new skills is related to implementation quality (Fixsen et al.
2005). Durlak and DuPre (2008, p. 338) add that training
Bshould not only help providers develop mastery in specific
intervention skills, but also attend to their expectations, motivation, and sense of self-efficacy, because the latter can affect
their future performance in and support of the new
innovation.^ In addition, training should include a clear statement of which components are considered Bcore^ components
and should not be altered, and which aspects of the intervention
can be adapted to achieve a better fit with local conditions.
Experimental research has shown that the addition of highquality technical assistance to training produces higher quality
implementation than does training alone. Such technical assistance maintains providers’ motivation and commitment, improves their skill levels where needed, and supports local
problem-solving efforts (Durlak and DuPre 2008). In particular, technical assistance that incorporates on-the-job coaching
has been repeatedly shown to be related to the quality of performance (Fixsen et al. 2005). Such coaching provides additional teaching while the practitioner is engaged in practice
activities, direct assessment and feedback on performance,
and emotional support. Also, as many providers do not selfidentify the need for technical assistance, the provision of
technical assistance should be proactive rather than on demand (Spoth et al. 2013).
Fidelity Assessment
5.a. Standard: Fidelity monitoring tools must be available to
providers. These tools should include measures of precursors to actual implementation such as completion of
training, acceptable practitioner-coach ratio, acceptable caseload, availability of colleagues with special
skills, and availability of necessary resource; integrity
and level of implementation/delivery of the core components; and acceptance, compliance, adherence, and/or
involvement of the target audience in the intervention
activities.
5.b. Standard: A system for documenting adaptations to core
components should be in place prior to initiating the
EBI. Adaptations should be addressed in ongoing technical assistance activities.
5.c. Standard: A system to support regular monitoring and
feedback using the available implementation monitoring tools should be in place.
Desirable Standard: Normative data on desired levels of
implementation keyed to the available implementation
measures should be provided.
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Fidelity to the core components of the intervention is essential. When implementation quality is monitored, implementation quality improves. Durlak and DuPre (2008) summarized results of meta-analyses showing that interventions
that monitored implementation obtained effect sizes two to
three times larger than interventions that reported no
monitoring.
Monitoring of implementation is important at each stage of
research. Standards guiding the development and use of fidelity measures and the reporting of fidelity information were
presented in the efficacy and effectiveness sections. During
scale-up efforts, the same implementation quality and fidelity
measures should be utilized, and a system to support regular
monitoring and feedback using these tools should be
developed.
While simply measuring implementation and providing
feedback to implementers will improve fidelity and quality,
fidelity assessments are likely to be most helpful if the level
of implementation observed during the scale-up attempt is
compared with a benchmark level that has been shown in prior
research to yield desired effects. Prior effectiveness trials will
have generated data necessary to provide this critical feedback.

high-quality implementation of EBIs involves integrating into
usual practice in the community or organization the training,
technical assistance, implementation monitoring, and feedback for the new practices for which standards have already
been discussed. As most of these topics have already been
incorporated into standards in the previous sections, no additional standards have been identified at this time for the sustainability phase.
However, we note that sustained use of EBIs can be facilitated by a community partnership or coalition, as discussed
above, that continually reviews and addresses problems as
they arise. The two community partnership/coalition models
discussed previously (PROSPER and Communities that Care)
have both been demonstrated in rigorous research to sustain
implementation of EBIs. Spoth et al. (2013) discuss alternative models that, for example, establish state-level technical
assistance systems, data systems that provide regular feedback
on implementation quality, organization development activities, and structures for addressing leadership turnover. Lastly,
they discuss the importance of establishing policies and mechanisms to sustain funding for EBIs.
Standards for Studying Outcomes of Scale-up Efforts

Improving Reach of the EBI
6. Standard: A system should be in place to support planning and monitoring of client recruitment. Planning
should include a careful assessment of local barriers to
participation and identification of strategies to overcome
these barriers. Recruitment efforts should be monitored
on an ongoing basis and planning should be renewed as
often as necessary to ensure high participation rates.
Scale-up efforts aim to achieve population impacts on important outcomes through sustained, high-quality implementation of EBIs. Failure to engage a large enough fraction of the
target population (e.g., persons, organizations, institutions
intended to participate) is a major impediment to the scaling
up of EBIs (Spoth et al. 2013). Failure to reach those segments
of population most at risk for experiencing problems (e.g.,
inner city neighborhoods, schools with weak leadership) and
traditionally underserved communities (e.g., rural communities) is especially problematic for prevention efforts. The most
effective methods for achieving high levels of participation of
the populations most likely to benefit from the intervention are
likely to differ across type of interventions and communities,
but careful attention to recruitment can improve the reach of
the intervention.
Sustainability Phase Many of the same factors that influence adoption decisions and implementation quality
also influence sustainability of interventions (Spoth
et al. 2013). In general, the challenge in achieving sustained

7. Standard: Scale-up efforts should be rigorously evaluated to
ensure that at least the anticipated immediate effects are
observed on outcomes of practical importance when the
intervention is implemented on a population level.
Consistent with the standards for efficacy and effectiveness
trials, the research design for these studies must be Bthe
strongest possible given the nature of the intervention, research question, and institutional framework within which
the intervention/research occurs. The design must also be
well executed, and any remaining threats to causal inference, or alternative explanations for observed effects, should
be addressed^ (Flay et al. 2005, p. 157). Randomized controlled trials, comparison time series designs, or regression
discontinuity designs are preferred, although creative adaptations to these designs are likely to be required.
Flay et al. (2005) included standards for providing evaluation tools to practitioners so they can evaluate the effects of
their efforts, but stopped short of providing guidance for more
rigorous evaluation of scale-up efforts. The assumption was
that once an intervention cleared all hurdles related to demonstrating efficacy and effectiveness, it would be likely to produce similar effects upon scale-up if implemented with fidelity. Recent failures to replicate initial strong findings in the
prevention field (referenced earlier) raise doubts about this
assumption. A similar phenomenon has been observed in biomedical research: Ioannidis (2005) compared effect sizes from
subsequent high-quality studies of highly cited clinical research studies published in three major general clinical
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journals. He found that the initially reported effects from a
third of these influential studies were subsequently either
contradicted or found to be substantially smaller than initially
reported. This research suggests that even effects that are
regarded as firmly established are often called into question
in subsequent studies.
Many possible explanations of this Bshrinking effects^ phenomenon exist, including initial publication and time-lag bias
favoring the more rapid and prominent publication of
Bpositive^ findings, as suggested by Ioannidis (2005).
Evolving treatment and counterfactual conditions might also
explain the phenomenon. Interventions often change over time,
presumably to meet evolving client needs. Similarly, the services to which clients would be exposed in the absence of an
EBI change over time. Services with overlapping goals are
frequently developed and implemented. This process creates
an ever-changing Btreatment as usual^ condition against which
the intervention of interest should be compared. This point was
recently made in response to evidence from a national evaluation of Head Start, a major early childhood program, indicating
that effects of the program were small and faded out more
rapidly than anticipated (Puma et al. 2012). Ludwig and
Phillips (2008) commented that alternative early childhood programs have been developed and evaluated since the initiation
of Head Start that are far more cost effective than Head Start.
Perhaps the availability of more effective alternatives renders
the program of interest less desirable to implement on a large
scale. Ludwig and Phillips (2008) also pointed out that the
evidence supporting Head Start’s long-term effects is from
studies of children who participated in Head Start in 1980 or
earlier. While the quality of the Head Start program has improved since that time, so has the quality of the environments to
which youth would be exposed in the absence of the program.
BWhich environment is improving faster in this horse race is
unclear^ (Ludwig and Phillips 2008, p. 261).
It is premature to draw conclusions about which mechanisms underlie the phenomenon of changing effect sizes over
time, and they are likely to vary by the intervention in question
as well. But it seems clear that we cannot necessarily expect
effect sizes to stay constant over time and that continued assessment of outcomes is needed after scale-up in order to
monitor changes in effect sizes over time and reevaluate prevention options. How should these scale-up efforts be studied?
Studies of scale-up efforts often focus on implementation
quality rather than outcomes (Chamberlain et al. 2008;
Forgatch and DeGarmo 2011). When they do measure outcomes, the research designs often do not meet high standards
of scientific rigor (Bloomquist et al. 2013; Schroeder et al.
2011; Winokur Early et al. 2012). Some dissemination attempts have been studied using randomized trials, however
(Rohrbach et al. 2010). Spoth et al. (2013), in the context of
a discussion of appropriate research designs for answering
questions about factors related to intervention adoption,

implementation, and sustainability, discussed challenges to
using traditional research designs appropriate for efficacy
and effectiveness trials to study scale-up efforts. In particular,
they suggested that it might be problematic to withhold EBIs
from a control group in a large-scale effort whose aim is to
provide effective programming to an entire population. They
discussed alternatives to the traditional randomized controlled
trial design, including Broll out^ designs in which organizations are randomly assigned to an implementation start-up
time rather than to a permanent treatment or control condition.
While such designs are not useful for documenting sustained
effects of interventions (because control cases eventually receive the treatment), they are an excellent choice for demonstrating that at least the initial outcomes of an intervention are
consistent with those found in earlier studies. State-of-the-art
methods have also been offered for analyzing data from randomized controlled trials to maximize what is learned from
scale-up efforts. For example, intent-to-treat analyses often
neglect important variation in the effect of an intervention
across individual characteristics, context, and time.
Examining such variation may be particularly important in
scale-up efforts that reach a broader swath of the population.
Brown et al. (2008) provide guidance in how data generated
from multilevel randomized designs can be analyzed to estimate heterogeneity of effects. Curran et al. (2013) also discuss
models for blending design components of effectiveness and
implementation research that may be particularly useful in the
studying of scale-up efforts.
Other rigorous designs such as comparison time series and
regression discontinuity may also be appropriate designs for
many scale-up efforts. If an intervention is initiated all at once
for an entire population, if archival measures of relevant outcomes (e.g., arrest rates, child maltreatment cases, substance
abuse-related emergency room visits) are available for several
time points before and after the start-date, and if a second population can be identified for which the same data points are
available but the intervention is not planned, comparison time
series is ideal. If a new service is to be provided on a limited
basis to individuals or families meeting certain criteria, if a scale
can be developed to assess these criteria, and if the
implementing organization agrees to use a cut-point on the scale
to assign subjects to receive services or not, a regression discontinuity design may be appropriate. In short, rigorous research
designs that effectively rule out alternative explanations for observed findings is as critical in evaluations of scale-up efforts as
it is in efficacy and effectiveness trials. Rigorous research designs can be employed creatively to study these efforts.
Desirable Standard: Before initiating rigorous scale-up
research, it is desirable to conduct an evaluability assessment to evaluate the likelihood that the evaluation of the
intervention in scale-up mode will result in useful
information.
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Whatever design is used, it is likely that conditions encountered in a scale-up effort will be less well suited for research
than conditions encountered in efficacy and even effectiveness
trials. Before initiating rigorous scale-up research, it is desirable to conduct an evaluability assessment to evaluate the
likelihood that the evaluation of the intervention in scale-up
mode will result in useful information.
Finally, the effectiveness section discussed the importance
of embedding research to inform scale-up efforts into ongoing
effectiveness trials. It goes without saying that research on
outcomes of scale-up efforts can likewise embed research to
answer important questions that will inform subsequent scaleup efforts.
The ideas presented in this section represent a major
change from the standards for broad dissemination articulated
a decade ago. These changes reflect the realization that the
marketing of a research product can no longer be viewed as
the end point of the preventive intervention research cycle.
Instead, we concur with the view of Spoth et al. (2013) of
the process of developing and testing preventive intervention
as ongoing and cyclical. Information from earlier stages informs decisions about scaling up. What is learned from studies
at later stages in the process is fed back to inform refinements
of the interventions, which are then tested in accordance with
the standards for efficacy and effectiveness trials articulated
earlier.

Conclusion
Establishing standards for Prevention Science is challenging.
The field is evolving rapidly and it lacks consensus on several
key issues. During the development of these revised standards, we debated several points that have great relevance
for the future of the field but about which prevention scientists
disagree. One of these is whether or not the field is well served
by continuing to embrace the traditional preventive intervention research cycle articulated 20 years ago (Mrazek and
Haggerty 1994). Another is the extent to which efforts to
disseminate preventive interventions should be constrained
by the rigorous standards of evidence articulated in this
document.
While most prevention scientists recognize that attention to
the translation of EBIs into population-level use has increased,
some believe that this implies that the earlier stages of research
(especially efficacy testing) are often not necessary.
According to this perspective, the field should focus mainly
on large-scale interventions and research on methods for effective scaling up of available practices. Proponents believe
that the preventive intervention research cycle encourages research on smaller scale strategies that are amenable to testing
through RCTs and discourages research on more scalable interventions. They further suggest that scaling up most

developer-based individual-level preventive interventions that
have been tested in RCTs is close to impossible and that research on such interventions should be discontinued in favor
of research on policies and practices that are either already
delivered at scale or that can feasibly be taken to scale.
A closely related issue pertains to the level of scientific
rigor implied in the standards and, in particular, the requirement that EBIs meet all of the standards for efficacy and effectiveness before being scaled up. Some question our ability
to meet increasing demand for prevention policies and services if we must limit the menu of available EBIs on the basis
of rigorous evidence suggesting that these policies or practices
have a reasonable probability of achieving a desirable outcome. Some believe that, although each of the standards articulated in this document is reasonable, the sum total of the
standards place most potentially effective interventions outside the boundaries of what will be recognized as worthy of
scale-up. Also, they point out that interventions evolve quickly once they are disseminated. Even if research on the initial
EBI satisfied all of the standards, what should be done as it
evolves?
Proponents of this perspective believe that we can afford to
accept some error in decisions about which interventions to
scale up. Legislators have to legislate, agencies have to create
policies, and communities will try interventions with or without the input of prevention scientists. We have the ethical
obligation to bring our best, even imperfect, evidence to bear
on these decisions. Some believe that little harm will be done
if we scale up EBIs that turn out not to be as effective as
implied in rigorous research. In short, this perspective holds
that we risk irrelevance and further separation from practice if
we cannot meet the demand for more preventive services and
that we cannot afford to limit our menu to the small fraction of
possible interventions that have been rigorously tested.
Another point of view (and the one that is reflected in the
revised standards) is that there is a critical need to develop and
test new interventions that can become the building blocks of
larger, effective prevention systems. Some of our Beffective^
interventions require further research and development to
boost their small to negligible effects. Others require updated
research to demonstrate continued effectiveness. Also, as the
population changes and new behaviors emerge, additional research is needed to design new or modify existing preventive
interventions to address current needs (e.g., cyberbullying).
Thus, continued research to develop and modify preventive
interventions is needed, and flexible use of the preventive
intervention research cycle as recommended in these standards will enhance the quality of this research.
Research is needed to support both large-scale policy and
legislative interventions and interventions targeting individuals. Despite the potential of larger scale interventions to reach
large proportions of the population, history shows that many
policy or legislative changes fail to change behavior. Demand
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for interventions aimed at providing effective services to individuals and families will always exist, and high-quality research will improve the menu of such services that can be
made available. The goal in promoting these interventions
should be that EBIs aimed at improving child care, social
competency instruction, family services, etc. replace less effective practices currently in place in schools, clinics, mental
health, and other youth-serving organizations. According to
this perspective, such broad changes to the nature of services
available to the population are as likely to bring about meaningful change as broad policy and legislative changes. The
need for continued research at all of these levels remains high.
In response to those who believe that rigorous efficacy
trials are appropriate only for small, individual-level interventions, we suggest that the challenges to using the research
designs recommended in this document are often exaggerated.
As discussed earlier in the document, rigorous methods for
drawing causal inferences about the effects of interventions
involving large aggregates exist, and the research literature
now contains many examples of the use of these designs to
study population-level interventions such as rural road paving,
water quality improvement, poverty reduction, and teacher
incentives.
Many of the concerns about the trade-offs between meeting
demand for prevention and holding to rigorous standards of
evidence might be resolved by recognizing that demand can
be met in a variety of ways that do not involve making claims
about the effectiveness of specific EBIs. This document establishes standards for the evidence that should be present to
support such claims. These standards do not pertain to basic
research in prevention or to a wide variety of preventionrelated activities such as advocacy and communication about
the nature of problems, precursors to dysfunction or well-being, and so on. A sizable improvement in many aspects of
well-being may result simply from the dissemination of
knowledge about conditions that are needed to ensure that
children and adolescents develop successfully, even in the
absence of specific EBIs. Agencies and legislators should look
to prevention scientists for such evidence, and prevention scientists should assist. These standards seek mainly to constrain
scientifically unsupported claims about the effectiveness of
specific EBIs. The underlying assumption in providing these
standards is that investing in high-quality research will produce higher quality evidence on which to base sound policies
and practices. More informed decisions will enhance wellbeing more in the long run than will best guesses based on
existing evidence.
This document updates SPR’s standards of evidence to
reflect important changes that have occurred over the past
decade that have implications for the design, implementation,
and reporting of Prevention Science intervention trials. As
noted in the BIntroduction,^ we chose to orient toward the
future, envisioning changes to the status quo that could

strengthen the impact of Prevention Science to improve the
public health and well-being. By endorsing the standards
contained in this document, SPR embraces a vision for the
future that encourages the application of science to improve
practices. This vision is consistent with Campbell’s (1968)
ideal of the Bexperimenting society^ in which actors remain
committed to reality-testing and are self-critical and honest.
They continually seek opportunities to test beliefs about the
world against reality and remain open to what the data say.
This experimental approach to improving the world implies an
ongoing commitment to self-study consistent with this new
generation of SPR standards.
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